_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725372761,5/24/2015 19:07:03,1642726765,5/24/2015 19:06:28,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:15:04,1642730232,5/24/2015 19:14:41,false,instagc,1,20312760,GBR,I2,Manchester,90.244.149.130,[CAUSES],[CAUSES],TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS caused by susceptible SALMONELLA,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:18:58,1642733464,5/24/2015 19:18:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:19:41,1642734384,5/24/2015 19:19:06,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:22:33,1642738184,5/24/2015 19:21:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS caused by SALMONELLA TYPHI,na,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:22:34,1642738288,5/24/2015 19:21:42,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:22:40,1642738501,5/24/2015 19:22:01,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",susceptible,n/a,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:23:36,1642739605,5/24/2015 19:23:17,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:25:56,1642740870,5/24/2015 19:25:36,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by susceptible SALMONELLA,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:30:23,1642743202,5/24/2015 19:30:03,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],caused by,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:31:53,1642743930,5/24/2015 19:31:36,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:35:29,1642745641,5/24/2015 19:35:09,false,neodev,1,29579905,GBR,"","",5.152.206.71,[TREATS] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:35:59,1642745858,5/24/2015 19:35:17,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],SALMONELLA INFECTIONS,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:36:15,1642746005,5/24/2015 19:35:10,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372761,5/24/2015 19:36:32,1642746132,5/24/2015 19:35:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],INFECTIONS,N/A,5,141,1,38,157,TWrex-cause,810843-FS1,280  TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS  Alternative for treatment of typhoid fever   +    (enteric fever) caused by susceptible  SALMONELLA TYPHI,TYPHOID FEVER AND OTHER SALMONELLA INFECTIONS,SALMONELLA TYPHI
725372762,5/24/2015 18:57:48,1642722354,5/24/2015 18:57:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],procedures,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:01:58,1642724222,5/24/2015 19:01:33,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:02:06,1642724286,5/24/2015 19:00:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[MANIFESTATION],[MANIFESTATION],complications of HEPATOCELLULAR CARCINOMA in patients with OBSTRUCTIVE JAUNDICE,na,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:02:10,1642724372,5/24/2015 19:00:09,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],as complications in patients with OBSTRUCTIVE JAUNDICE,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:04:03,1642725352,5/24/2015 19:03:46,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:04:13,1642725449,5/24/2015 19:03:14,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with and,n/a,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:04:50,1642725712,5/24/2015 19:04:02,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"They may also occur as complications of HEPATOCELLULAR CARCINOMA 90 chronic granulomatous disease, or OBSTRUCTIVE JAUNDICE",N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:05:07,1642725902,5/24/2015 19:04:40,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEPATOCELLULAR CARCINOMA and OBSTRUCTIVE JAUNDICE,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:10:03,1642728072,5/24/2015 19:08:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],complications of,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:11:39,1642728771,5/24/2015 19:11:22,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",complications,n/a,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:14:06,1642729844,5/24/2015 19:13:02,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:17:26,1642731704,5/24/2015 19:16:37,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],complications of,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:22:49,1642738706,5/24/2015 19:21:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",may also occur as,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:26:32,1642741088,5/24/2015 19:25:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with,n/a,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372762,5/24/2015 19:26:36,1642741132,5/24/2015 19:26:11,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",of or with,N/A,198,40,1,217,64,TWrex-cause,814090-FS1,"They may also occur as complications of HEPATOCELLULAR CARCINOMA  90   chronic granulomatous disease,  91 , 92   or percutaneous transhepatic biliary drainage procedures in patients with cancer and OBSTRUCTIVE JAUNDICE",OBSTRUCTIVE JAUNDICE,HEPATOCELLULAR CARCINOMA
725372763,5/24/2015 22:11:56,1642793224,5/24/2015 22:11:37,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"undetermined significance,",N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 22:27:59,1642799792,5/24/2015 22:27:06,false,points4rewards,1,28703583,USA,"","",97.73.85.52,[PART_OF],[PART_OF],Plasma cell disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 22:42:50,1642804477,5/24/2015 22:41:20,false,tremorgames,1,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Plasma cell disorders include,Says they are part of plasma disorders,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 22:53:01,1642807319,5/24/2015 22:52:18,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],"MONOCLONAL GAMMOPATHY of undetermined significance, WALDENSTRSM MACROGLOBULINEMIA and",n/a,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:23:05,1642815375,5/24/2015 23:22:08,false,instagc,1,30721651,USA,NY,New York,69.203.110.153,[IS_A],[IS_A],include,i chose something,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:23:08,1642815383,5/24/2015 23:22:02,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[MANIFESTATION],[MANIFESTATION],include,Na,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:35:07,1642818269,5/24/2015 23:34:43,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:40:17,1642819741,5/24/2015 23:38:51,false,prodege,1,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Plasma cell disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:40:30,1642819801,5/24/2015 23:38:56,false,elite,1,31722487,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Plasma cell disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:49:21,1642821869,5/24/2015 23:48:34,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",Plasma cell disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:49:32,1642821914,5/24/2015 23:48:42,false,bitcoinget,1,28503763,USA,CA,San Francisco,107.217.186.64,[ASSOCIATED_WITH],[ASSOCIATED_WITH],disorders include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/24/2015 23:59:32,1642824991,5/24/2015 23:58:59,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Plasma cell disorders include MONOCLONAL GAMMOPATHY multiple myeloma, WALDENSTRSM MACROGLOBULINEMIA and",n/a,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/25/2015 00:00:51,1642825411,5/24/2015 23:59:17,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[IS_A] [PART_OF] [LOCATION],"[LOCATION]
[IS_A]
[PART_OF]","Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, WALDENSTRSM MACROGLOBULINEMIA",N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/25/2015 00:17:24,1642830645,5/25/2015 00:17:14,false,prodege,1,12656479,CAN,NB,Moncton,142.167.60.47,[PART_OF],[PART_OF],disorders,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372763,5/25/2015 00:25:25,1642833430,5/25/2015 00:24:37,false,bitcoinget,1,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],include,N/A,30,124,1,50,182,TWrex-cause,814890-FS1,"Plasma cell disorders include MONOCLONAL GAMMOPATHY of undetermined significance, multiple myeloma, solitary extramedullary plasmacytoma, WALDENSTRSM MACROGLOBULINEMIA and amyloidosis.",MONOCLONAL GAMMOPATHY,WALDENSTRSM MACROGLOBULINEMIA
725372764,5/24/2015 18:57:16,1642722118,5/24/2015 18:56:47,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[IS_A],[IS_A],is a type,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:00:08,1642723436,5/24/2015 18:58:58,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],ACD is a type IV,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:00:48,1642723798,5/24/2015 18:59:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ACD is IV CELL MEDIATED HYPERSENSITIVITY REACTION,na,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:01:27,1642724020,5/24/2015 19:00:46,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [TREATS],"[TREATS]
[IS_A]",is a an,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:03:13,1642724882,5/24/2015 19:02:56,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],is a,n/a,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:03:45,1642725163,5/24/2015 19:03:35,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[IS_A],[IS_A],is a type,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:04:01,1642725332,5/24/2015 19:03:47,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:04:39,1642725654,5/24/2015 19:04:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[IS_A],[IS_A],ACD is a IV CELL MEDIATED HYPERSENSITIVITY REACTION,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:08:57,1642727630,5/24/2015 19:08:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],is a type,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:11:21,1642728656,5/24/2015 19:11:04,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",a type,n/a,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:13:01,1642729406,5/24/2015 19:12:44,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],is a type,n/a,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:16:35,1642730995,5/24/2015 19:15:59,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],is a type,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:21:02,1642736302,5/24/2015 19:20:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is a,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:26:07,1642740916,5/24/2015 19:25:50,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is a,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372764,5/24/2015 19:26:51,1642741298,5/24/2015 19:25:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],is a,N/A,29,53,1,31,92,TWrex-cause,811264-FS1,Allergic contact dermatitis (ACD):  ACD is a type IV CELL MEDIATED HYPERSENSITIVITY REACTION that has 2 phases: sensitization to an antigen and response on reexposure.,ACD,CELL MEDIATED HYPERSENSITIVITY REACTION
725372765,5/24/2015 19:03:50,1642725215,5/24/2015 19:03:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:11:51,1642728888,5/24/2015 19:11:24,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POSTTRAUMATIC STRESS DISORDER from international consensus on DEPRESSION AND ANXIETY,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:13:13,1642729435,5/24/2015 19:12:15,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],from,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:15:50,1642730557,5/24/2015 19:14:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"It is a group's name talking about that illness, no realtion",148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:16:05,1642730678,5/24/2015 19:15:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Consensus statement update on,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:16:49,1642731120,5/24/2015 19:15:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],POSTTRAUMATIC STRESS DISORDER from group DEPRESSION AND ANXIETY,na,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:19:09,1642733702,5/24/2015 19:18:42,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],consensus group,n/a,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:19:28,1642733988,5/24/2015 19:18:21,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],statement update from the international consensus group on DEPRESSION,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:20:02,1642734778,5/24/2015 19:19:44,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:26:30,1642741083,5/24/2015 19:25:35,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[OTHER],[OTHER],from the consensus,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:29:53,1642742930,5/24/2015 19:29:35,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from the,n/a,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:31:10,1642743565,5/24/2015 19:30:46,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],on,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:31:37,1642743773,5/24/2015 19:31:00,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],statement from,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:31:50,1642743899,5/24/2015 19:31:17,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",POSTTRAUMATIC STRESS DISORDER consensus DEPRESSION AND ANXIETY,NONE,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372765,5/24/2015 19:32:48,1642744363,5/24/2015 19:31:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],update on,N/A,148,76,1,169,105,TWrex-cause,813962-FS1,"Ballenger JC, Davidson JR, Lecrubier Y et al. Consensus statement update on POSTTRAUMATIC STRESS DISORDER from the international consensus group on DEPRESSION AND ANXIETY",DEPRESSION AND ANXIETY,POSTTRAUMATIC STRESS DISORDER
725372766,5/24/2015 21:45:13,1642785002,5/24/2015 21:44:52,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],manifestations of the disease,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 22:11:37,1642793155,5/24/2015 22:11:13,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[OTHER],[OTHER],survey study,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 22:27:01,1642799457,5/24/2015 22:26:36,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[MANIFESTATION],[MANIFESTATION],manifestations of,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 22:41:20,1642804015,5/24/2015 22:40:26,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],consecutive sample of patients,Says there is a connection,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 22:52:17,1642807165,5/24/2015 22:52:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS to be manifestations of the disease,n/a,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:22:02,1642815111,5/24/2015 23:21:40,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[MANIFESTATION],[MANIFESTATION],manifestations,Na,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:22:07,1642815128,5/24/2015 23:21:45,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[SYMPTOM],[SYMPTOM],found,i chose something,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:34:41,1642818113,5/24/2015 23:33:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],manifestations of,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:38:22,1642819190,5/24/2015 23:37:19,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",found,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:38:49,1642819314,5/24/2015 23:37:46,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],found,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:38:50,1642819317,5/24/2015 23:37:53,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH],[ASSOCIATED_WITH],study of,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:48:41,1642821774,5/24/2015 23:47:49,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[ASSOCIATED_WITH],[ASSOCIATED_WITH],found,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:56:02,1642823993,5/24/2015 23:54:09,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS to be manifestations of the disease,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/24/2015 23:58:58,1642824851,5/24/2015 23:58:29,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[MANIFESTATION],[MANIFESTATION],patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS to cutaneous manifestations of the disease,n/a,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372766,5/25/2015 00:17:13,1642830583,5/25/2015 00:16:48,false,prodege,1.0,12656479,CAN,NB,Moncton,142.167.60.47,[CAUSES],[CAUSES],manifestations,N/A,69,58,1,97,62,TWrex-cause,813841-FS1,• A survey study of a consecutive sample of patients with MEN1 found MULTIPLE FACIAL ANGIOFIBROMAS and collagenomas to be cutaneous manifestations of the disease ( 22.,MULTIPLE FACIAL ANGIOFIBROMAS,MEN1
725372767,5/24/2015 19:34:10,1642745070,5/24/2015 19:33:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],from,n/a,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:38:51,1642747125,5/24/2015 19:38:36,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS],[TREATS],statement,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:39:29,1642747317,5/24/2015 19:39:08,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Consensus GENERALIZED ANXIETY DISORDER and ANXIETY,NONE,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:40:46,1642747834,5/24/2015 19:40:03,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",statement on,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:41:01,1642747936,5/24/2015 19:40:20,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ANXIETY DISORDER,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:42:00,1642748295,5/24/2015 19:40:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],Consensus Group on Depression ANXIETY,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:42:36,1642748481,5/24/2015 19:41:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],statement on from,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:43:11,1642748703,5/24/2015 19:42:44,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:44:49,1642749313,5/24/2015 19:44:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],GENERALIZED ANXIETY DISORDER,n/a,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 19:45:46,1642749695,5/24/2015 19:45:37,false,neodev,1,32562748,CAN,BC,Vancouver,108.180.140.140,[CONTRAINDICATES] [LOCATION],"[LOCATION]
[CONTRAINDICATES]",GENERALIZED ANXIETY DISORDER,kids,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 20:08:09,1642755997,5/24/2015 20:07:55,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS],[TREATS],statement,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 20:18:35,1642758816,5/24/2015 20:18:11,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[PART_OF],[PART_OF],from the International Consensus Group on Depression and,no comment,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 20:21:11,1642759342,5/24/2015 20:20:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,n/a,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 20:22:15,1642759654,5/24/2015 20:21:54,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],Consensus statement,-,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372767,5/24/2015 20:23:36,1642759980,5/24/2015 20:22:33,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],on Depression and,N/A,35,23,1,41,51,TWrex-cause,814777-FS1,Consensus statement on GENERALIZED ANXIETY DISORDER from the International Consensus Group on Depression and ANXIETY,ANXIETY,GENERALIZED ANXIETY DISORDER
725372768,5/24/2015 21:11:30,1642774730,5/24/2015 21:11:10,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[MANIFESTATION],[MANIFESTATION],clinical presentation,I didn´t select none.,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 21:42:47,1642784394,5/24/2015 21:42:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],has a clinical presentation of,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 21:52:45,1642787378,5/24/2015 21:51:52,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],presentation of,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:08:17,1642791987,5/24/2015 22:08:03,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],caused by,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:15:21,1642794665,5/24/2015 22:14:55,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SYMPTOM],[SYMPTOM],clinical presentation,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:22:07,1642798021,5/24/2015 22:21:36,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:31:10,1642800810,5/24/2015 22:30:24,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],presentation of,Says this happens during the disease,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:38:40,1642803077,5/24/2015 22:37:49,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],presentation of,n/a,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 22:49:53,1642806499,5/24/2015 22:49:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING,n/a,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:16:33,1642813552,5/24/2015 23:16:14,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",has a clinical presentation of,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:19:01,1642814178,5/24/2015 23:18:40,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],clinical presentation,Na,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:19:43,1642814326,5/24/2015 23:19:13,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[SYMPTOM],[SYMPTOM],clinical presentation of,i chose something,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:25:41,1642815984,5/24/2015 23:25:31,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[MANIFESTATION],[MANIFESTATION],presentation,n/a,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:27:09,1642816312,5/24/2015 23:26:37,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],presentation of,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372768,5/24/2015 23:29:00,1642816715,5/24/2015 23:28:24,false,clixsense,1.0,6344072,CAN,BC,Burnaby,172.218.166.58,[SYMPTOM],[SYMPTOM],a clinical presentation,N/A,58,0,1,72,26,TWrex-cause,813963-FS1,"INFLAMMATORY BREAST CANCER has a clinical presentation of BREAST SWELLING erythema, warmth, and a peau d'orange appearance (characterized by a dimpled appearance caused by tumor infiltration of intradermal lymphatics); it may or may not be associated with a mass. These lesions are associated with a high risk of recurrence of local disease and with distant metastases.",BREAST SWELLING,INFLAMMATORY BREAST CANCER
725372769,5/24/2015 22:23:40,1642798579,5/24/2015 22:23:16,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH] [CONTRAINDICATES],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",with continuation of,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 22:34:02,1642801552,5/24/2015 22:32:31,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],of patients receiving,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 22:55:52,1642808229,5/24/2015 22:55:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],WITHDRAWAL SYNDROME receiving ORAL CLONIDINE,n/a,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 23:26:17,1642816114,5/24/2015 23:25:56,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],therapy,Na,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 23:26:26,1642816137,5/24/2015 23:25:46,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],patients receiving,Says patients take it for the disease,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 23:41:10,1642820038,5/24/2015 23:40:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SIDE_EFFECT],[SIDE_EFFECT],associated with,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 23:50:50,1642822182,5/24/2015 23:50:03,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[OTHER],[OTHER],patients receiving,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/24/2015 23:57:33,1642824503,5/24/2015 23:56:51,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[OTHER],[OTHER],patients receiving,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 00:01:35,1642825671,5/24/2015 23:59:20,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",(reported in about 1% of patients,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 00:10:27,1642828617,5/25/2015 00:08:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],WITHDRAWAL SYNDROME in patients receiving ORAL CLONIDINE,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 00:12:05,1642829090,5/25/2015 00:11:37,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SIDE_EFFECT],[SIDE_EFFECT],WITHDRAWAL SYNDROME (reported in 1% receiving ORAL CLONIDINE,n/a,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 00:36:53,1642836858,5/25/2015 00:36:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,none,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 01:06:58,1642845467,5/25/2015 01:06:19,false,gptking,1.0,31799065,USA,IL,Marion,50.45.40.174,[CAUSES],[CAUSES],WITHDRAWAL SYNDROME ORAL CLONIDINE,N/A,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 01:11:47,1642847173,5/25/2015 01:11:25,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[SYMPTOM],[SYMPTOM],(reported in about 1% of patients receiving ORAL CLONIDINE,n/a,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372769,5/25/2015 01:51:20,1642859543,5/25/2015 01:50:09,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]","therapy, associated with",n/a,3,67,-1,21,81,TWrex-cause,800258-FS1,"b  WITHDRAWAL SYNDROME (reported in about 1% of patients receiving ORAL CLONIDINE is more pronounced after abrupt cessation of long term therapy than after short term (1 2 months) therapy, and has usually been associated with previous administration of high oral dosages (>1.2 mg daily) and/or with continuation of concomitant β adrenergic blocking therapy.",WITHDRAWAL SYNDROME,ORAL CLONIDINE
725372770,5/24/2015 20:51:19,1642767567,5/24/2015 20:50:47,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],form of,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 21:07:57,1642773684,5/24/2015 21:07:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",CHRONIC PAIN SYNDROME (see CHRONIC PAIN ),N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 21:08:40,1642773890,5/24/2015 21:08:10,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[PART_OF],[PART_OF],a form of,I didn´t select none.,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 21:40:54,1642783812,5/24/2015 21:40:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],is probably a form of,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 21:44:42,1642784860,5/24/2015 21:44:21,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],(see,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:00:23,1642789702,5/24/2015 21:58:57,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],(see,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:03:57,1642790628,5/24/2015 22:03:37,false,prodege,1,10959404,USA,CA,Studio City,108.217.110.104,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(see,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:05:20,1642790960,5/24/2015 22:05:06,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[LOCATION],[LOCATION],"of the vulva,",N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:17:59,1642796081,5/24/2015 22:17:10,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[CAUSES],[CAUSES],probably a form of,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:28:02,1642799807,5/24/2015 22:27:30,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(see CHRONIC PAIN,Says they are related,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:36:20,1642802395,5/24/2015 22:36:05,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[MANIFESTATION],[MANIFESTATION],form of,n/a,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 22:48:19,1642806087,5/24/2015 22:48:05,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],CHRONIC PAIN SYNDROME (see CHRONIC PAIN,n/a,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 23:04:06,1642810347,5/24/2015 23:02:47,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",(see,N/A,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 23:17:06,1642813659,5/24/2015 23:16:28,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[IS_A],[IS_A],(see CHRONIC PAIN,i chose something,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372770,5/24/2015 23:17:44,1642813880,5/24/2015 23:16:58,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A] [PART_OF] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",CHRONIC PAIN SYNDROME (see CHRONIC PAIN,n/a,73,73,1,84,94,TWrex-cause,812911-FS1,"Vulvar vestibulitis (localized vulvar dysesthesia) is probably a form of CHRONIC PAIN SYNDROME (see  CHRONIC PAIN ) of the vulva, in which the nervous system, from peripheral receptors to the cerebral cortex, is sensitized and remodeled for unknown reasons.",CHRONIC PAIN,CHRONIC PAIN SYNDROME
725372771,5/24/2015 20:49:55,1642767025,5/24/2015 20:49:30,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],reaction,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 20:57:08,1642769766,5/24/2015 20:56:38,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],DRUG HYPERSENSITIVITY DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,n/a,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 21:05:27,1642772736,5/24/2015 21:04:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SIDE_EFFECT] [CONTRAINDICATES],"[CONTRAINDICATES]
[SIDE_EFFECT]",DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 21:07:08,1642773437,5/24/2015 21:06:32,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],mediated reaction to a,I didn´t select none.,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 21:39:00,1642783197,5/24/2015 21:38:25,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],reaction to a,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 21:43:00,1642784450,5/24/2015 21:42:33,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],is an,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 21:53:14,1642787543,5/24/2015 21:52:30,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],immune mediated reaction,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:02:23,1642790229,5/24/2015 22:01:42,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[OTHER],[OTHER],reaction,reaction,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:04:35,1642790774,5/24/2015 22:04:11,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SIDE_EFFECT],[SIDE_EFFECT],immune mediated reaction,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:15:52,1642794904,5/24/2015 22:15:03,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SIDE_EFFECT],[SIDE_EFFECT],reaction to,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:25:40,1642799112,5/24/2015 22:25:01,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[CAUSES],[CAUSES],reaction,Says it causes this reaction,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:34:55,1642801990,5/24/2015 22:34:38,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SIDE_EFFECT],[SIDE_EFFECT],reaction to a,n/a,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:47:14,1642805734,5/24/2015 22:46:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],DRUG HYPERSENSITIVITY DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,n/a,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 22:59:47,1642809212,5/24/2015 22:58:13,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SYMPTOM] [MANIFESTATION] [SIDE_EFFECT] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",is an immune mediated reaction to,N/A,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372771,5/24/2015 23:13:01,1642812801,5/24/2015 23:12:18,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SIDE_EFFECT] [MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",DRUG HYPERSENSITIVITY is an immune mediated reaction to DRUG,n/a,0,0,1,20,4,TWrex-cause,810180-FS1,DRUG HYPERSENSITIVITY  DRUG HYPERSENSITIVITY is an immune mediated reaction to a DRUG,DRUG HYPERSENSITIVITY,DRUG
725372772,5/24/2015 18:59:20,1642723049,5/24/2015 18:58:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:04:03,1642725339,5/24/2015 19:03:26,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of of,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:04:32,1642725615,5/24/2015 19:03:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],Advise of the first missed menses,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:05:19,1642726025,5/24/2015 19:05:03,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[CONTRAINDICATES],[CONTRAINDICATES],withdraw the first missed,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:05:55,1642726261,5/24/2015 19:05:22,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CONTRAINDICATES],[CONTRAINDICATES],withdraw BROMOCRIPTINE at the time of confirmation of PREGNANCY,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:06:21,1642726472,5/24/2015 19:04:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],withdraw BROMOCRIPTINE at the time of confirmation of PREGNANCY,na,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:06:26,1642726512,5/24/2015 19:05:59,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[CONTRAINDICATES],[CONTRAINDICATES],withdraw BROMOCRIPTINE at confirmation of PREGNANCY,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:07:11,1642726845,5/24/2015 19:06:03,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CONTRAINDICATES],[CONTRAINDICATES],and then to withdraw,n/a,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:11:27,1642728681,5/24/2015 19:10:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],to withdraw,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:12:36,1642729244,5/24/2015 19:12:20,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],subsequent confirmation,n/a,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:16:04,1642730659,5/24/2015 19:15:27,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:19:37,1642734282,5/24/2015 19:18:47,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CONTRAINDICATES],[CONTRAINDICATES],withdraw at confirmation of PREGNANCY,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:25:48,1642740821,5/24/2015 19:24:54,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],withdraw,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:28:04,1642742040,5/24/2015 19:26:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],to withdraw BROMOCRIPTINE,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372772,5/24/2015 19:28:34,1642742255,5/24/2015 19:26:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],BROMOCRIPTINE,N/A,255,171,-1,263,184,TWrex-cause,803131-FS1,"B]  Specific recommendation: • Advise women with prolactin secreting microadenomas who are taking cabergoline to consider switching to bromocriptine, and then to withdraw BROMOCRIPTINE at the time of the first missed menses and subsequent confirmation of PREGNANCY",PREGNANCY,BROMOCRIPTINE
725372773,5/24/2015 19:57:49,1642753347,5/24/2015 19:57:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],prevents stroke,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:01:01,1642754118,5/24/2015 20:00:06,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [OTHER],"[IS_A]
[OTHER]",a other,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:47:14,1642765976,5/24/2015 20:46:48,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],higher risk,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:47:15,1642765988,5/24/2015 20:46:18,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],prevents,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:48:44,1642766518,5/24/2015 20:47:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [IS_A],"[PREVENTS]
[IS_A]",Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN ACP,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:49:42,1642766856,5/24/2015 20:49:13,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevents,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:53:27,1642768447,5/24/2015 20:53:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 20:59:12,1642770458,5/24/2015 20:57:53,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],Warfarin prevents stroke in nonrheumatic ATRIAL FIBRILLATION WARFARIN,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:00:53,1642771113,5/24/2015 21:00:37,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],higher risk,I didn´t select none.,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:25:49,1642779052,5/24/2015 21:25:39,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[CAUSES],[CAUSES],ATRIAL,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:35:19,1642782192,5/24/2015 21:34:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],prevents,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:36:30,1642782443,5/24/2015 21:36:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],prevents,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:46:48,1642785443,5/24/2015 21:44:20,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],higher risk,N/A,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:52:06,1642787127,5/24/2015 21:51:56,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevents,n/a,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372773,5/24/2015 21:57:25,1642788761,5/24/2015 21:56:26,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[TREATS],[TREATS],prevents,n,135,191,-1,153,199,TWrex-cause,805034-FS1,Review: Warfarin prevents stroke in nonrheumatic atrial fibrillation but has a higher risk for hemorrhage than other agents  Keywords: ATRIAL FIBRILLATION Cerebrovascular accident Hemorrhage WARFARIN  ACP Journal Club.,ATRIAL FIBRILLATION,WARFARIN
725372774,5/24/2015 22:22:50,1642798290,5/24/2015 22:22:38,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PART_OF],[PART_OF],until signs,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 22:30:22,1642800544,5/24/2015 22:29:50,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],are initiated for,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 22:54:23,1642807743,5/24/2015 22:53:37,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYPOVOLEMIA OR HEMORRHAGIC SHOCK until signs of HYPOVOLEMIA,n/a,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:17:16,1642813720,5/24/2015 23:16:16,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],until signs of remit—up,"Says it will be alleviated, leading to the belief that it is a symptom.",70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:24:51,1642815788,5/24/2015 23:24:06,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],initiated,Na,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:38:20,1642819176,5/24/2015 23:36:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,they are both the same thing,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:44:35,1642820745,5/24/2015 23:43:11,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH],[ASSOCIATED_WITH],signs remit—up,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:53:30,1642823206,5/24/2015 23:51:51,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",are initiated until signs of,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:54:29,1642823546,5/24/2015 23:52:22,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[ASSOCIATED_WITH],[ASSOCIATED_WITH],any patient with until signs of,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/24/2015 23:55:09,1642823732,5/24/2015 23:53:24,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",initiated as for any patient with until signs of,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/25/2015 00:04:17,1642826487,5/25/2015 00:02:59,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IV fluids are initiated for patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK,n/a,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/25/2015 00:05:26,1642826841,5/25/2015 00:03:30,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",IV fluids are initiated for patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/25/2015 00:33:22,1642835783,5/25/2015 00:32:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],signs,none,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/25/2015 00:38:40,1642837465,5/25/2015 00:35:50,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],until signs of remit—up,n/a,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372774,5/25/2015 01:04:54,1642844899,5/25/2015 01:02:48,false,gptking,1.0,31799065,USA,IL,Marion,50.45.40.174,[SYMPTOM],[SYMPTOM],HYPOVOLEMIA HEMORRHAGIC SHOCK HYPOVOLEMIA,N/A,70,70,1,101,81,TWrex-cause,812361-FS1,"Fluid resuscitation:  IV fluids are initiated as for any patient with HYPOVOLEMIA OR HEMORRHAGIC SHOCK (see  Intravenous Fluid Resuscitation ): healthy adults are given normal saline IV in 500  to 1000 mL aliquots until signs of HYPOVOLEMIA remit—up to a maximum of 2 L (for children 20 mL/kg, which may be repeated once.",HYPOVOLEMIA OR HEMORRHAGIC SHOCK,HYPOVOLEMIA
725372775,5/24/2015 19:47:37,1642750278,5/24/2015 19:47:10,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NONE,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 19:53:05,1642751747,5/24/2015 19:52:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treated with,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 19:54:48,1642752378,5/24/2015 19:54:16,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treated with,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:17:52,1642758612,5/24/2015 20:17:31,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treated with,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:37:20,1642763369,5/24/2015 20:37:04,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treated,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:38:37,1642763723,5/24/2015 20:38:18,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:39:13,1642763851,5/24/2015 20:38:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:40:30,1642764211,5/24/2015 20:40:20,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],treated with,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:45:24,1642765455,5/24/2015 20:45:10,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treated,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:48:23,1642766418,5/24/2015 20:48:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],NEONATAL SCABIES treated with PERMETHRIN CREAM.,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:49:47,1642766889,5/24/2015 20:49:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 20:56:04,1642769503,5/24/2015 20:55:34,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],treated with,I didn´t select none.,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 21:03:59,1642772243,5/24/2015 21:03:44,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treated with,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 21:19:26,1642777186,5/24/2015 21:19:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treated with,N/A,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372775,5/24/2015 21:23:50,1642778377,5/24/2015 21:23:37,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],treated,n/a,0,30,-1,15,49,TWrex-cause,805159-FS1,NEONATAL SCABIES treated with PERMETHRIN 5% CREAM.,NEONATAL SCABIES,PERMETHRIN 5% CREAM
725372776,5/24/2015 18:55:36,1642721282,5/24/2015 18:55:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 18:56:05,1642721536,5/24/2015 18:55:26,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],characterized by THROMBOCYTOPENIA,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 18:57:43,1642722290,5/24/2015 18:56:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) characterized by THROMBOCYTOPENIA,na,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 18:58:19,1642722664,5/24/2015 18:57:28,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 18:59:20,1642723047,5/24/2015 18:58:38,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],characterized by,n/a,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:02:43,1642724626,5/24/2015 19:02:06,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",characterized by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:02:51,1642724708,5/24/2015 19:01:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],THROMBOTIC THROMBOCYTOPENIC PURPURA disorders characterized by THROMBOCYTOPENIA,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:02:54,1642724723,5/24/2015 19:01:38,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[IS_A],[IS_A],THROMBOTIC THROMBOCYTOPENIC PURPURA characterized by THROMBOCYTOPENIA,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:06:33,1642726536,5/24/2015 19:05:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],characterized by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:10:07,1642728112,5/24/2015 19:09:39,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],THROMBOCYTOPENIA,n/a,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:11:41,1642728810,5/24/2015 19:11:00,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],characterized,n/a,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:14:37,1642730016,5/24/2015 19:14:04,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],characterized by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:16:19,1642730804,5/24/2015 19:14:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",characterized by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:22:36,1642738342,5/24/2015 19:21:23,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characterized by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372776,5/24/2015 19:24:10,1642740007,5/24/2015 19:23:43,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],by,N/A,193,0,1,208,35,TWrex-cause,814544-FS1,"THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AND HEMOLYTIC UREMIC SYNDROME (HUS)  THROMBOTIC THROMBOCYTOPENIC PURPURA and hemolytic uremic syndrome are acute, fulminant disorders characterized by THROMBOCYTOPENIA and microangiopathic hemolytic anemia.",THROMBOCYTOPENIA,THROMBOTIC THROMBOCYTOPENIC PURPURA
725372777,5/24/2015 22:14:34,1642794291,5/24/2015 22:12:46,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluated with,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 22:29:45,1642800396,5/24/2015 22:28:47,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can be evaluated with,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 22:53:36,1642807493,5/24/2015 22:53:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BRONCHIAL HYPERRESPONSIVENESS is the concentration of METHACHOLINE,n/a,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:16:15,1642813494,5/24/2015 23:15:37,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can be evaluated,Says it can be used to test for,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:24:05,1642815548,5/24/2015 23:23:35,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],defined,Na,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:36:37,1642818647,5/24/2015 23:36:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluated with,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:43:10,1642820461,5/24/2015 23:41:39,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluated with a histamine challenge test,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:51:02,1642822237,5/24/2015 23:49:53,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [CONTRAINDICATES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CONTRAINDICATES]",evaluated with defined as the provocative concentration,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:52:23,1642822698,5/24/2015 23:50:57,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",defined as the provocative concentration of,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/24/2015 23:52:21,1642822702,5/24/2015 23:50:53,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can also be evaluated with a histamine challenge test,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/25/2015 00:02:58,1642826103,5/25/2015 00:00:01,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",BRONCHIAL HYPERRESPONSIVENESS can be evaluated with histamine challenge test The PC20 defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,n/a,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/25/2015 00:03:30,1642826289,5/25/2015 00:02:36,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BRONCHIAL HYPERRESPONSIVENESS can be evaluated with a histamine challenge test,N/A,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/25/2015 00:32:07,1642835343,5/25/2015 00:31:27,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],evaluated,none,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/25/2015 00:35:49,1642836570,5/25/2015 00:35:11,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],can be evaluated with a test,n/a,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372777,5/25/2015 01:02:47,1642844372,5/25/2015 00:59:52,false,gptking,1.0,31799065,USA,IL,Marion,50.45.40.174,[TREATS],[TREATS],BRONCHIAL HYPERRESPONSIVENESS METHACHOLINE,n/a,0,141,-1,28,153,TWrex-cause,803019-FS1,BRONCHIAL HYPERRESPONSIVENESS can also be evaluated with a histamine challenge test  The PC20 is defined as the provocative concentration of METHACHOLINE inducing a 20% drop in FEV1.,BRONCHIAL HYPERRESPONSIVENESS,METHACHOLINE
725372778,5/24/2015 19:09:06,1642727715,5/24/2015 19:08:48,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:16:45,1642731049,5/24/2015 19:16:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[CAUSES],[CAUSES],STREPTOCOCCAL INFECTIONS caused by susceptible STREPTOCOCCI,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:21:12,1642736520,5/24/2015 19:20:50,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:21:37,1642737111,5/24/2015 19:20:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of (without caused by,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:24:17,1642740094,5/24/2015 19:24:04,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused,n/a,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:24:32,1642740270,5/24/2015 19:24:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],STREPTOCOCCAL INFECTIONS caused by STREPTOCOCCI,na,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:24:38,1642740285,5/24/2015 19:24:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:25:37,1642740704,5/24/2015 19:24:25,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:28:14,1642742100,5/24/2015 19:27:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by susceptible STREPTOCOCCI,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:32:35,1642744227,5/24/2015 19:32:15,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],caused by,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:32:58,1642744433,5/24/2015 19:32:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:37:12,1642746345,5/24/2015 19:36:44,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[CAUSES],[CAUSES],STREPTOCOCCAL INFECTIONS caused by susceptible STREPTOCOCCI,NONE,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:37:18,1642746361,5/24/2015 19:36:44,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [CAUSES],"[TREATS]
[CAUSES]
[PART_OF]",Treatment of caused,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:37:39,1642746708,5/24/2015 19:36:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],INFECTIONS,N/A,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372778,5/24/2015 19:37:41,1642746725,5/24/2015 19:37:27,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]",STREPTOCOCCAL INFECTIONS Treatment,a,23,142,1,46,154,TWrex-cause,810225-FS1,"5 ,   30 ,   57  Other STREPTOCOCCAL INFECTIONS  Treatment of mild to moderately severe infections (without bacteremia) caused by susceptible STREPTOCOCCI including upper respiratory tract infections and scarlet fever.",STREPTOCOCCAL INFECTIONS,STREPTOCOCCI
725372779,5/24/2015 21:11:52,1642774878,5/24/2015 21:11:33,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[CAUSES],[CAUSES],is probably a,I didn´t select none.,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 21:43:09,1642784484,5/24/2015 21:42:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 21:53:20,1642787565,5/24/2015 21:52:46,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],is a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:08:56,1642792292,5/24/2015 22:08:18,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SIDE_EFFECT],[SIDE_EFFECT],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:15:41,1642794820,5/24/2015 22:15:22,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:22:58,1642798332,5/24/2015 22:22:12,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SYMPTOM],[SYMPTOM],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:32:28,1642801216,5/24/2015 22:31:11,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is probably a,Says it could be a part of the disease,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:38:58,1642803172,5/24/2015 22:38:41,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],is probably a,n/a,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 22:50:27,1642806645,5/24/2015 22:49:55,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],SUBACUTE SCLEROSING PANENCEPHALITIS is a PERSISTENT MEASLES VIRUS INFECTION,n/a,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:17:40,1642813865,5/24/2015 23:16:34,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[IS_A],[IS_A],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:19:37,1642814310,5/24/2015 23:19:02,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[MANIFESTATION],[MANIFESTATION],probably PERSISTENT,Na,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:19:58,1642814439,5/24/2015 23:19:44,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[IS_A],[IS_A],is probably a,i chose something,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:27:43,1642816477,5/24/2015 23:27:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:28:22,1642816605,5/24/2015 23:27:06,false,clixsense,1.0,6344072,CAN,BC,Burnaby,172.218.166.58,[IS_A],[IS_A],is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372779,5/24/2015 23:28:29,1642816629,5/24/2015 23:27:04,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is probably a,N/A,0,57,1,34,91,TWrex-cause,814948-FS1,SUBACUTE SCLEROSING PANENCEPHALITIS (SSPE) is probably a PERSISTENT MEASLES VIRUS INFECTION (see  Measles.,SUBACUTE SCLEROSING PANENCEPHALITIS,PERSISTENT MEASLES VIRUS INFECTION
725372780,5/24/2015 19:01:22,1642724002,5/24/2015 19:00:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(e.g.,",N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:06:22,1642726474,5/24/2015 19:06:10,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",N/A,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:07:43,1642726990,5/24/2015 19:07:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[NONE],[NONE],N/A,Two separate conditions being described,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:08:29,1642727432,5/24/2015 19:07:08,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[OTHER],[OTHER],other,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:08:51,1642727569,5/24/2015 19:08:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ARTHRITIS, CHARCOT'S JOINT",N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:11:00,1642728530,5/24/2015 19:09:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"rheumatoid ARTHRITIS, CHARCOT'S JOINT",na,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:11:32,1642728715,5/24/2015 19:10:37,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],may result from,n/a,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:13:11,1642729433,5/24/2015 19:12:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],may result from infections,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:14:05,1642729834,5/24/2015 19:11:17,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"result from infections neuropathies (e.g., CHARCOT'S",N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:16:56,1642731214,5/24/2015 19:16:34,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"rheumatoid ARTHRITIS, systemic",n/a,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:17:41,1642731959,5/24/2015 19:17:22,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:22:31,1642738099,5/24/2015 19:21:40,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],"may result from neuropathies (e.g., CHARCOT'S JOINT",N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:28:27,1642742199,5/24/2015 19:27:58,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[OTHER],[OTHER],other,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:29:10,1642742567,5/24/2015 19:28:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],may result from,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372780,5/24/2015 19:29:34,1642742785,5/24/2015 19:27:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],infections,N/A,323,261,-1,337,270,TWrex-cause,802172-FS1,"ETIOLOGY: Arthritis may result from infections (e.g., rheumatic fever, staphylococcal infections, gonorrhea, tuberculosis), metabolic disturbances (e.g., gout, calcium pyrophosphate crystal disease), multisystem autoimmune diseases (e.g., psoriasis, rheumatoid ARTHRITIS, systemic lupus erythematosus), neuropathies (e.g., CHARCOT'S JOINT joint trauma, endocrine diseases (e.g., acromegaly), and other illnesses.",CHARCOT'S JOINT,ARTHRITIS
725372781,5/24/2015 20:49:06,1642766690,5/24/2015 20:48:31,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",receiving,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 20:52:47,1642768190,5/24/2015 20:51:36,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],occurs,n/a,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 20:56:13,1642769539,5/24/2015 20:55:44,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],Warnings/Precautions Warnings Fetal/Neonatal Morbidity and Mortality Extremely high risk of severe birth defects,n/a,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 21:03:53,1642772181,5/24/2015 21:03:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],(possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 21:05:21,1642772717,5/24/2015 21:02:40,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],high risk,I didn´t select none.,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 21:37:59,1642782917,5/24/2015 21:37:36,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CONTRAINDICATES],[CONTRAINDICATES],occurs while receiving,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 21:40:21,1642783633,5/24/2015 21:39:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CONTRAINDICATES],[CONTRAINDICATES],while receiving,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 21:52:00,1642787089,5/24/2015 21:50:54,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[OTHER],[OTHER],while receiving,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:00:56,1642789806,5/24/2015 21:59:53,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[NONE],[NONE],none,don't use it while pregnant,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:03:27,1642790530,5/24/2015 22:03:06,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SIDE_EFFECT],[SIDE_EFFECT],occurs while receiving,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:14:20,1642794183,5/24/2015 22:13:38,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[CONTRAINDICATES],[CONTRAINDICATES],Warnings/Precautions,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:24:07,1642798722,5/24/2015 22:23:38,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[CAUSES],[CAUSES],occurs,Says it could cause,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:34:15,1642801619,5/24/2015 22:33:59,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],occurs while receiving,n/a,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:42:41,1642804443,5/24/2015 22:40:58,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[OTHER],[OTHER],Warnings/Precautions,N/A,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372781,5/24/2015 22:46:42,1642805599,5/24/2015 22:46:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],n/a,medication that should not be taken during pregnancy,147,180,-1,155,191,TWrex-cause,803143-FS1,Warnings/Precautions  Warnings  Fetal/Neonatal Morbidity and Mortality  Extremely high risk of severe birth defects (possibly life threatening) if PREGNANCY occurs while receiving THALIDOMIDE in any amount.,PREGNANCY,THALIDOMIDE
725372782,5/24/2015 19:57:20,1642753188,5/24/2015 19:56:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],"had lower rates for nonfatal reinfarction,",n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:00:03,1642753915,5/24/2015 19:59:09,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:46:15,1642765710,5/24/2015 20:45:07,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],lower rates,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:46:47,1642765906,5/24/2015 20:46:10,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],outcomes.,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:47:25,1642766058,5/24/2015 20:46:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group the 2 WARFARIN groups did not differ for these outcomes.",n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:49:12,1642766724,5/24/2015 20:48:53,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],groups,n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:53:03,1642768303,5/24/2015 20:52:27,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group",n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 20:57:44,1642769957,5/24/2015 20:55:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],lower rates THROMBOEMBOLIC STROKE WARFARIN,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:00:35,1642771025,5/24/2015 20:59:51,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],had lower rates,I didn´t select none.,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:25:38,1642778987,5/24/2015 21:25:27,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[LOCATION],[LOCATION],groups,n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:34:56,1642782080,5/24/2015 21:34:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],had lower rates,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:36:01,1642782333,5/24/2015 21:34:32,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],Both,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:44:19,1642784756,5/24/2015 21:43:06,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],lower rates,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:51:55,1642787042,5/24/2015 21:51:33,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],groups,n/a,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372782,5/24/2015 21:59:23,1642789277,5/24/2015 21:58:47,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[TREATS],[TREATS],outcomes.,N/A,96,162,-1,116,170,TWrex-cause,804630-FS1,"Both warfarin groups had lower rates for the main composite measure, nonfatal reinfarction, and THROMBOEMBOLIC STROKE than the aspirin alone group (Table); the 2 WARFARIN groups did not differ for these outcomes.",THROMBOEMBOLIC STROKE,WARFARIN
725372783,5/24/2015 19:00:47,1642723786,5/24/2015 19:00:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],receiving,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:06:09,1642726406,5/24/2015 19:06:00,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[TREATS],[TREATS],for management of,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:07:04,1642726766,5/24/2015 19:05:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:07:23,1642726930,5/24/2015 19:07:09,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:08:21,1642727328,5/24/2015 19:07:53,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:09:29,1642727829,5/24/2015 19:08:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS,na,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:10:33,1642728361,5/24/2015 19:10:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for management of,n/a,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:11:17,1642728636,5/24/2015 19:10:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],for management of JUVENILE,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:12:27,1642729163,5/24/2015 19:12:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for management of,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:16:32,1642730944,5/24/2015 19:15:50,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],receiving,n/a,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:17:21,1642731563,5/24/2015 19:17:07,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],management,n/a,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:21:39,1642737145,5/24/2015 19:20:51,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",for management of,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:27:53,1642741931,5/24/2015 19:27:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],management of,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:27:53,1642741933,5/24/2015 19:27:33,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372783,5/24/2015 19:28:17,1642742118,5/24/2015 19:28:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],receiving for management,n/a,84,52,-1,112,65,TWrex-cause,804872-FS1,146  Adverse effects observed in children receiving SULFASALAZINE for management of JUVENILE RHEUMATOID ARTHRITIS generally are similar to those observed in adults with rheumatoid arthritis.,JUVENILE RHEUMATOID ARTHRITIS,SULFASALAZINE
725372784,5/24/2015 20:48:08,1642766320,5/24/2015 20:47:53,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 20:51:00,1642767441,5/24/2015 20:50:25,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 20:55:07,1642769115,5/24/2015 20:54:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE the treatment of children with CENTRAL PRECOCIOUS PUBERTY,n/a,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:01:59,1642771522,5/24/2015 21:01:37,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],in the treatment,I didn´t select none.,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:02:14,1642771581,5/24/2015 21:01:06,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE treatment of children with CENTRAL PRECOCIOUS PUBERTY,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:36:25,1642782431,5/24/2015 21:36:03,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the treatment of children with,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:38:57,1642783183,5/24/2015 21:37:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:49:13,1642786197,5/24/2015 21:48:55,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],treatment of children,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 21:58:46,1642789101,5/24/2015 21:58:27,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[TREATS],[TREATS],treatment,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:02:40,1642790314,5/24/2015 22:02:24,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],treatment of,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:12:22,1642793401,5/24/2015 22:11:27,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],in the treatment of,N/A,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:22:52,1642798281,5/24/2015 22:22:12,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],treatment of children with,Says this is what treats the ailment,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:33:35,1642801453,5/24/2015 22:32:53,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment,n/a,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:39:54,1642803546,5/24/2015 22:38:23,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[TREATS],[TREATS],in the treatment of,N/a,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372784,5/24/2015 22:46:13,1642805423,5/24/2015 22:45:57,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in treatment of children with CENTRAL PRECOCIOUS PUBERTY,n/a,146,66,-1,171,111,TWrex-cause,803542-FS1,"Clemons RD, Kappy MS, Stuart TE et al. Long term effectiveness of DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE in the treatment of children with CENTRAL PRECOCIOUS PUBERTY",CENTRAL PRECOCIOUS PUBERTY,DEPOT GONADOTROPIN RELEASING HORMONE ANALOGUE
725372785,5/24/2015 19:03:25,1642724996,5/24/2015 19:02:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:11:23,1642728659,5/24/2015 19:10:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[SYMPTOM],[SYMPTOM],MS accompanied by SPASTICITY,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:12:12,1642729038,5/24/2015 19:11:26,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with is of is by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:14:48,1642730095,5/24/2015 19:14:08,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],is accompanied by,n/a,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:15:15,1642730262,5/24/2015 19:14:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],MS is accompanied by SPASTICITY,na,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:15:28,1642730379,5/24/2015 19:15:04,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is accompanied by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:18:20,1642732683,5/24/2015 19:16:51,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is accompanied by SPASTICITY,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:18:41,1642733173,5/24/2015 19:18:25,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied,n/a,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:19:43,1642734423,5/24/2015 19:19:26,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],accompanied,n/a,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:25:34,1642740657,5/24/2015 19:25:12,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],accompanied by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:29:34,1642742776,5/24/2015 19:29:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],accompanied by,n/a,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:30:42,1642743341,5/24/2015 19:30:24,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",with is of is by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:31:44,1642743844,5/24/2015 19:30:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],accompanied by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:31:47,1642743857,5/24/2015 19:30:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],accompanied by,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372785,5/24/2015 19:31:47,1642743864,5/24/2015 19:30:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MS,N/A,88,29,1,97,31,TWrex-cause,814039-FS1,The weakness associated with MS is of the upper motor neuron type and is accompanied by SPASTICITY and increased reflexes.,SPASTICITY,MS
725372786,5/24/2015 18:56:45,1642721833,5/24/2015 18:56:23,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],long term therapy,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 18:58:56,1642722856,5/24/2015 18:58:06,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],long term therapy for TOXOPLASMIC,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 18:59:30,1642723155,5/24/2015 18:59:02,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CLINDAMYCIN VS PYRIMETHAMINE therapy TOXOPLASMIC ENCEPHALITIS,na,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:00:42,1642723770,5/24/2015 19:00:05,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:02:54,1642724731,5/24/2015 19:02:29,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],long term therapy for,n/a,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:03:33,1642725101,5/24/2015 19:03:23,false,bitcoinget,1,21614812,USA,NJ,Burlington,50.153.125.0,[TREATS],[TREATS],therapy for,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:03:46,1642725147,5/24/2015 19:03:23,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as therapy for TOXOPLASMIC ENCEPHALITIS,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:04:14,1642725450,5/24/2015 19:03:44,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as long term therapy for TOXOPLASMIC ENCEPHALITIS,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:08:39,1642727498,5/24/2015 19:07:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],long term therapy for,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:11:04,1642728552,5/24/2015 19:10:45,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",long term therapy,n/a,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:12:43,1642729267,5/24/2015 19:12:31,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:15:57,1642730638,5/24/2015 19:15:36,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],long term therapy for,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:20:08,1642734930,5/24/2015 19:19:28,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],therapy for,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:25:46,1642740796,5/24/2015 19:25:23,false,neodev,1,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372786,5/24/2015 19:26:30,1642741082,5/24/2015 19:25:04,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CLINDAMYCIN PYRIMETHAMINE,N/A,131,54,-1,154,82,TWrex-cause,800313-FS1,"Katlama C, De Wit S, O'Doherty E et al. Pyrimethamine CLINDAMYCIN VS PYRIMETHAMINE sulfadiazine as acute and long term therapy for TOXOPLASMIC ENCEPHALITIS in patients with AIDS.",TOXOPLASMIC ENCEPHALITIS,CLINDAMYCIN VS PYRIMETHAMINE
725372787,5/24/2015 19:45:56,1642749726,5/24/2015 19:45:37,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[SYMPTOM],[SYMPTOM],PHN involves three types of pain:,NONE,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 19:52:15,1642751541,5/24/2015 19:51:39,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",involves,n/a,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 19:52:48,1642751661,5/24/2015 19:51:59,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of a with a or a or or is with,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:15:56,1642758206,5/24/2015 20:15:03,false,neodev,1,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of a or an with a or a or or by is with with,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:34:34,1642762726,5/24/2015 20:33:50,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],involves three types pain:,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:36:18,1642763136,5/24/2015 20:35:55,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],involves three types of pain:,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:36:29,1642763178,5/24/2015 20:34:39,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",n/a,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:39:27,1642763963,5/24/2015 20:39:07,false,clixsense,1,23197581,NLD,11,Den Haag,82.217.5.55,[SYMPTOM],[SYMPTOM],involves three types of pain:,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:44:16,1642765151,5/24/2015 20:43:32,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],involves,n/a,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:46:43,1642765884,5/24/2015 20:46:28,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],burning,Na,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:46:48,1642765916,5/24/2015 20:46:14,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality;,n/a,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:47:14,1642765966,5/24/2015 20:46:28,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],PHN involves PAIN,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 20:53:56,1642768727,5/24/2015 20:53:30,false,neodev,1,31910622,GBR,X4,Blackwood,78.148.171.155,[SYMPTOM],[SYMPTOM],involves,I didn´t select none.,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 21:02:48,1642771791,5/24/2015 21:02:18,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involves,n/a,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372787,5/24/2015 21:11:55,1642774849,5/24/2015 21:10:25,false,neodev,1,32350671,USA,DE,Wilmington,162.223.94.90,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PHN involves three types of pain:,N/A,97,0,1,100,3,TWrex-cause,812932-FS1,"PHN involves three types of pain: a constant burning or deep aching; an intermittent spontaneous PAIN with a jabbing or lancinating quality; and a superficial, sharp, or radiating pain or itching provoked by light touch (allodynia), which is present in 90% of persons with PHN and often interferes with sleep.",PAIN,PHN
725372788,5/24/2015 19:00:23,1642723574,5/24/2015 18:59:47,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],DISEASE,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:05:50,1642726198,5/24/2015 19:04:49,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",or by of of with,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:05:55,1642726256,5/24/2015 19:05:33,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[ASSOCIATED_WITH] [OTHER] [NONE],"[ASSOCIATED_WITH]
[OTHER]
[NONE]",N/A,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:07:08,1642726819,5/24/2015 19:06:24,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:07:49,1642727057,5/24/2015 19:07:10,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[NONE],[NONE],N/A,"It's all the title of the same thing, so they're not related, they are one.",263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:08:51,1642727561,5/24/2015 19:07:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,na,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:10:17,1642728193,5/24/2015 19:08:26,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"as far as I can tell, this is one term in the sentence above, they belong together?",263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:10:46,1642728462,5/24/2015 19:08:30,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[NONE],[NONE],N/A,is a disease,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:12:08,1642729019,5/24/2015 19:11:46,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],"e.g.,",N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:15:49,1642730540,5/24/2015 19:13:01,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],and,n/a,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:17:06,1642731374,5/24/2015 19:16:47,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:20:50,1642736009,5/24/2015 19:20:06,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:27:26,1642741609,5/24/2015 19:26:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],"other lesions, e.g.,",N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:28:03,1642742031,5/24/2015 19:27:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],collecting,n/a,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372788,5/24/2015 19:28:42,1642742304,5/24/2015 19:27:13,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",cause presentations of,N/A,263,225,-1,307,262,TWrex-cause,802183-FS1,"Can be asymptomatic or rarely cause pain  Should be differentiated by its radiographic appearance from asymmetric presentations of ADPKD and other lesions, e.g., multilocular cystic nephroma, cystic renal cell carcinoma, and SEGMENTAL MULTICYSTIC RENAL DYSPLASIA AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE  Fusiform dilatation of collecting ducts with marked renal enlargement in infancy.",AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE,SEGMENTAL MULTICYSTIC RENAL DYSPLASIA
725372789,5/24/2015 21:44:50,1642784901,5/24/2015 21:44:33,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],Caused by or infected with,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 22:11:12,1642793047,5/24/2015 22:10:03,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],Caused by,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 22:19:44,1642796999,5/24/2015 22:18:09,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],concerning,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 22:26:32,1642799293,5/24/2015 22:26:11,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[CAUSES],[CAUSES],Caused by,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 22:40:24,1642803778,5/24/2015 22:39:46,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],concerning,Says it's associated with,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 22:51:58,1642807042,5/24/2015 22:51:47,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],FUNGUS; concerning MYCOSIS,n/a,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:21:39,1642814928,5/24/2015 23:21:22,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],Caused,Na,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:21:45,1642814976,5/24/2015 23:21:32,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[CAUSES],[CAUSES],Caused by infected with,i chose something,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:33:54,1642817870,5/24/2015 23:32:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],Caused by,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:36:33,1642818642,5/24/2015 23:35:24,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",Caused by or infected,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:37:22,1642818865,5/24/2015 23:36:00,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]",Caused by or infected with,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:37:52,1642818992,5/24/2015 23:35:13,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",concerning,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:47:48,1642821563,5/24/2015 23:45:07,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[NONE],[NONE],N/A,looks like it's the beginning of another sentence talking about another aspect of something similar. but there is no clear relationship.,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:54:09,1642823388,5/24/2015 23:53:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],Caused by FUNGUS; MYCOSIS,N/A,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372789,5/24/2015 23:58:28,1642824734,5/24/2015 23:58:00,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[NONE],[NONE],n/a,not enough info given,80,61,1,86,67,TWrex-cause,812383-FS1,mycotic    (             audio )  Caused by or infected with FUNGUS; concerning MYCOSIS,MYCOSIS,FUNGUS
725372790,5/24/2015 22:23:15,1642798416,5/24/2015 22:23:03,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[OTHER],[OTHER],a study,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 22:32:26,1642801208,5/24/2015 22:30:58,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[MANIFESTATION],[MANIFESTATION],a study of,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 22:55:19,1642807992,5/24/2015 22:55:05,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PG ADULT ONSET AMENORRHEA:,n/a,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:25:44,1642816000,5/24/2015 23:24:43,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[NONE],[NONE],N/A,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:25:55,1642816034,5/24/2015 23:25:32,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],study,Na,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:40:19,1642819752,5/24/2015 23:39:01,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"PG seems to be the initials of the researchers name, so no relation is valid in this case.",45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:50:02,1642822011,5/24/2015 23:49:15,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",PG ADULT ONSET AMENORRHEA:,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:56:50,1642824226,5/24/2015 23:55:56,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[PART_OF],[PART_OF],McDonough PG ADULT ONSET AMENORRHEA:,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/24/2015 23:58:26,1642824723,5/24/2015 23:56:41,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[PART_OF],[PART_OF],PG ADULT,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 00:00:24,1642825240,5/24/2015 23:58:40,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PART_OF],[PART_OF],PG ADULT ONSET AMENORRHEA:,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 00:06:49,1642827365,5/25/2015 00:05:36,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[PART_OF],[PART_OF],PG ADULT ONSET AMENORRHEA:,n/a,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 00:08:26,1642827902,5/25/2015 00:06:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",PG ADULT ONSET AMENORRHEA: study of 262 patients.,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 00:36:02,1642836635,5/25/2015 00:35:33,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],study,none,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 01:06:19,1642845282,5/25/2015 01:05:30,false,gptking,1,31799065,USA,IL,Marion,50.45.40.174,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PG ADULT ONSET AMENORRHEA:,N/A,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372790,5/25/2015 01:11:24,1642847042,5/25/2015 01:10:45,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[OTHER],[OTHER],McDonough PG,n/a,45,42,-1,66,44,TWrex-cause,803793-FS1,"Reindollar RH, Novak M, Tho SP, McDonough PG ADULT ONSET AMENORRHEA: a study of 262 patients.",ADULT ONSET AMENORRHEA,PG
725372791,5/24/2015 21:43:49,1642784583,5/24/2015 21:43:25,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Maintenance Therapy Oral: Recommended initial dosages and dosage escalations for,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 21:54:53,1642787994,5/24/2015 21:54:25,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],initial dosages,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:09:25,1642792512,5/24/2015 22:09:08,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[IS_A],[IS_A],receiving,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:17:26,1642795726,5/24/2015 22:16:51,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],Maintenance Therapy,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:24:28,1642798795,5/24/2015 22:23:53,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],Maintenance Therapy Oral:,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:37:49,1642802861,5/24/2015 22:37:22,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],dosage escalations for,Says you can take it for,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:39:49,1642803505,5/24/2015 22:39:29,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],dosage for,n/a,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 22:51:05,1642806813,5/24/2015 22:50:48,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BIPOLAR DISORDER Therapy for LAMOTRIGINE,na,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:20:19,1642814529,5/24/2015 23:19:53,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],dosages dosage,Na,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:20:43,1642814625,5/24/2015 23:20:14,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],dosage escalations for LAMOTRIGINE,i chose something,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:20:49,1642814666,5/24/2015 23:19:21,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[OTHER],[OTHER],Recommended initial dosages and dosage escalations for,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:29:52,1642816933,5/24/2015 23:29:18,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],BIPOLAR DISORDER Maintenance Therapy Oral: LAMOTRIGINE,n/a,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:30:14,1642817043,5/24/2015 23:29:01,false,clixsense,1,6344072,CAN,BC,Burnaby,172.218.166.58,[OTHER],[OTHER],dosage escalations,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:30:41,1642817135,5/24/2015 23:28:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Maintenance Therapy,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372791,5/24/2015 23:33:50,1642817861,5/24/2015 23:31:38,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",Recommended dosage escalations for,N/A,3,110,-1,18,121,TWrex-cause,803794-FS1,"a  BIPOLAR DISORDER  >     Maintenance Therapy  Oral:  Recommended initial dosages and dosage escalations for LAMOTRIGINE in patients receiving valproic acid or receiving carbamazepine, phenobarbital, phenytoin, primidone, or rifampin (without valproic acid) are summarized in Table 5.",BIPOLAR DISORDER,LAMOTRIGINE
725372792,5/24/2015 19:44:17,1642749144,5/24/2015 19:44:01,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],CLONAZEPAM of PANIC DISORDER,NONE,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 19:45:25,1642749558,5/24/2015 19:45:06,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 19:50:01,1642751008,5/24/2015 19:49:35,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 19:50:34,1642751223,5/24/2015 19:50:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 19:51:53,1642751506,5/24/2015 19:51:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CLONAZEPAM,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 19:53:23,1642751917,5/24/2015 19:52:13,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:13:20,1642757517,5/24/2015 20:13:06,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:25:42,1642760343,5/24/2015 20:25:34,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:31:06,1642761938,5/24/2015 20:30:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:31:45,1642762109,5/24/2015 20:30:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,n/a,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:34:28,1642762711,5/24/2015 20:33:48,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:36:00,1642763061,5/24/2015 20:35:36,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,n/a,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:37:45,1642763495,5/24/2015 20:37:29,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],for the treatment of,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:41:32,1642764498,5/24/2015 20:41:23,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372792,5/24/2015 20:43:58,1642765039,5/24/2015 20:43:19,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CLONAZEPAM for the treatment of PANIC DISORDER,N/A,57,18,-1,70,28,TWrex-cause,803398-FS1,The alprazolam to CLONAZEPAM switch for the treatment of PANIC DISORDER,PANIC DISORDER,CLONAZEPAM
725372793,5/24/2015 19:34:43,1642745311,5/24/2015 19:34:26,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:40:22,1642747682,5/24/2015 19:40:05,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[CAUSES],[CAUSES],PASTEURELLOSIS caused infection genus PASTEURELLA,NONE,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:41:46,1642748205,5/24/2015 19:41:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:43:35,1642748831,5/24/2015 19:41:30,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PASTEURELLA,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:43:45,1642748885,5/24/2015 19:43:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by infection with,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:44:16,1642749129,5/24/2015 19:43:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:44:33,1642749203,5/24/2015 19:43:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",A caused by with of,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 19:45:58,1642749739,5/24/2015 19:45:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by infection with bacteria of,n/a,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:09:11,1642756300,5/24/2015 20:08:47,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",A caused by with of,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:20:23,1642759159,5/24/2015 20:19:41,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[MANIFESTATION],[MANIFESTATION],audio A disease caused by infection with bacteria of the genus,no comment,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:22:51,1642759827,5/24/2015 20:22:38,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:23:24,1642759915,5/24/2015 20:22:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],PASTEURELLOSIS A disease caused by infection with bacteria of the genus PASTEURELLA,n/a,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:25:32,1642760315,5/24/2015 20:24:57,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:27:34,1642760828,5/24/2015 20:27:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372793,5/24/2015 20:28:13,1642761066,5/24/2015 20:28:03,false,neodev,1.0,31789301,USA,"","",178.62.105.32,[NONE],[NONE],no,no,0,106,1,13,117,TWrex-cause,810361-FS1,PASTEURELLOSIS    (                    audio )  A disease caused by infection with bacteria of the genus  PASTEURELLA,PASTEURELLOSIS,PASTEURELLA
725372794,5/24/2015 19:47:01,1642750013,5/24/2015 19:46:33,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],CLOFAZIMINE monthly doses treat LEPROMATOUS LEPROSY,NONE,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 19:52:53,1642751689,5/24/2015 19:52:38,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],required to treat,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 19:54:13,1642752212,5/24/2015 19:53:44,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",of treat,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:17:27,1642758545,5/24/2015 20:17:05,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",of treat,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:37:03,1642763315,5/24/2015 20:36:42,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",doses,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:38:17,1642763629,5/24/2015 20:36:18,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],required to treat,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:38:33,1642763716,5/24/2015 20:37:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:40:19,1642764173,5/24/2015 20:40:04,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],are required to treat,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:45:10,1642765405,5/24/2015 20:44:55,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treat,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:48:03,1642766273,5/24/2015 20:47:25,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Daily dapsone and CLOFAZIMINE monthly doses of rifampin for 24 months required to treat LEPROMATOUS LEPROSY,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:49:12,1642766717,5/24/2015 20:48:21,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CLOFAZIMINE required to treat LEPROMATOUS LEPROSY,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 20:55:31,1642769333,5/24/2015 20:54:50,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],required to treat,I didn´t select none.,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 21:03:42,1642772141,5/24/2015 21:03:21,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treat,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 21:19:00,1642777058,5/24/2015 21:17:55,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treat,N/A,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372794,5/24/2015 21:23:35,1642778329,5/24/2015 21:23:19,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],plus,n/a,97,18,-1,115,29,TWrex-cause,804521-FS1,Daily dapsone and CLOFAZIMINE plus monthly doses of rifampin for 24 months are required to treat LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725372795,5/24/2015 21:12:30,1642775100,5/24/2015 21:11:56,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TEST,I didn´t select none.,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 21:43:24,1642784520,5/24/2015 21:43:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],therapy,N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 21:54:23,1642787858,5/24/2015 21:53:22,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TEST,N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:09:08,1642792350,5/24/2015 22:08:57,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],"vaccine,",N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:16:50,1642795399,5/24/2015 22:15:42,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[ASSOCIATED_WITH],[ASSOCIATED_WITH],therapy,N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:23:49,1642798610,5/24/2015 22:23:02,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[NONE],[NONE],N/A,just a list of medical terms,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:37:22,1642802669,5/24/2015 22:36:51,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TUBERCULIN SKIN TEST,Says it is a test for,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:39:28,1642803364,5/24/2015 22:38:59,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnoses,n/a,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 22:50:47,1642806747,5/24/2015 22:50:28,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],TUBERCULOSIS TUBERCULIN SKIN TEST,n/a,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:19:20,1642814233,5/24/2015 23:17:41,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[NONE],[NONE],N/A,These are listed as numbered items in an appendix therefore have no relation to each other.,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:19:52,1642814409,5/24/2015 23:19:39,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],therapy,Na,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:20:13,1642814486,5/24/2015 23:19:59,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[IS_A],[IS_A],;,i chose something,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:28:48,1642816680,5/24/2015 23:27:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SKIN TEST,N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:29:17,1642816741,5/24/2015 23:28:54,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TUBERCULOSIS TUBERCULIN SKIN TEST,n/a,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372795,5/24/2015 23:31:33,1642817297,5/24/2015 23:28:58,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],immunological therapy,N/A,13,78,-1,24,98,TWrex-cause,803036-FS1,"SEE:  illus: TUBERCULOSIS ;  illus: TUBERCULOSIS ;   immunological therapy ;  TUBERCULIN SKIN TEST ;  vaccine, BCG;   Nursing Diagnoses Appendix.",TUBERCULOSIS,TUBERCULIN SKIN TEST
725372796,5/24/2015 20:47:51,1642766248,5/24/2015 20:47:36,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],caused,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 20:48:16,1642766374,5/24/2015 20:47:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 20:50:23,1642767230,5/24/2015 20:50:08,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 20:54:33,1642768924,5/24/2015 20:54:00,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",i Yaws Alternative to penicillin G for treatment of caused by TREPONEMA PERTENUE.,n/a,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:01:03,1642771185,5/24/2015 21:00:12,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:01:33,1642771356,5/24/2015 21:01:14,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[CAUSES],[CAUSES],caused by,I didn´t select none.,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:36:02,1642782335,5/24/2015 21:35:43,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:37:38,1642782830,5/24/2015 21:37:20,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:48:54,1642786067,5/24/2015 21:47:13,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],caused by,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:52:30,1642787307,5/24/2015 21:52:21,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 21:58:25,1642789039,5/24/2015 21:57:55,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[CAUSES],[CAUSES],caused,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 22:02:23,1642790225,5/24/2015 22:01:50,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],caused by,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 22:11:21,1642793104,5/24/2015 22:10:46,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],treatment,N/A,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 22:22:11,1642798029,5/24/2015 22:21:32,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[CAUSES],[CAUSES],caused by,Directly states caused by,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372796,5/24/2015 22:35:37,1642802195,5/24/2015 22:35:25,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment,n/a,68,84,1,71,102,TWrex-cause,810886-FS1,"c ,   116 ,   i  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.",YAWS,TREPONEMA PERTENUE
725372797,5/24/2015 20:49:28,1642766822,5/24/2015 20:49:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],occurs rarely,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 20:53:33,1642768494,5/24/2015 20:52:48,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[IS_A],[IS_A],occurs,n/a,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 20:56:38,1642769632,5/24/2015 20:56:14,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,n/a,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 21:04:29,1642772395,5/24/2015 21:03:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYDROCEPHALUS occurs rarely with PORENCEPHALY,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 21:06:21,1642773161,5/24/2015 21:05:34,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs rarely,I didn´t select none.,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 21:38:22,1642783044,5/24/2015 21:38:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],occurs rarely with,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 21:42:32,1642784332,5/24/2015 21:40:22,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CONTRAINDICATES],[CONTRAINDICATES],occurs rarely,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 21:52:30,1642787296,5/24/2015 21:52:02,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],occurs rarely,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:01:41,1642790017,5/24/2015 22:00:58,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:04:10,1642790666,5/24/2015 22:03:27,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs rarely with,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:14:55,1642794518,5/24/2015 22:14:27,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[MANIFESTATION],[MANIFESTATION],occurs rarely with,N/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:24:55,1642798884,5/24/2015 22:24:08,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],occurs with,Says can happen during,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:34:36,1642801794,5/24/2015 22:34:16,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],rarely with,n/a,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:43:28,1642804653,5/24/2015 22:42:42,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[MANIFESTATION],[MANIFESTATION],occurs rarely with,n/A,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372797,5/24/2015 22:46:53,1642805653,5/24/2015 22:46:43,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYDROCEPHALUS occurs rarely with PORENCEPHALY,n/a,12,45,1,24,57,TWrex-cause,813879-FS1,Progressive HYDROCEPHALUS occurs rarely with PORENCEPHALY,HYDROCEPHALUS,PORENCEPHALY
725372798,5/24/2015 19:45:36,1642749653,5/24/2015 19:45:17,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],ADJUVANT INTERFERON ALFA 2A treatment primary STAGE II CUTANEOUS MELANOMA,NONE,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 19:51:37,1642751441,5/24/2015 19:51:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment in,n/a,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 19:51:55,1642751498,5/24/2015 19:51:23,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS],"[TREATS]
[IS_A]",A treatment,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 19:56:37,1642752986,5/24/2015 19:55:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:14:59,1642757999,5/24/2015 20:14:24,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [TREATS],"[TREATS]
[IS_A]",A treatment,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:33:49,1642762609,5/24/2015 20:33:11,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:34:33,1642762725,5/24/2015 20:33:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA,n/a,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:35:52,1642763021,5/24/2015 20:35:33,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:39:07,1642763831,5/24/2015 20:38:44,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],treatment in,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:43:31,1642764886,5/24/2015 20:43:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:46:12,1642765702,5/24/2015 20:45:51,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA,n/a,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:46:26,1642765751,5/24/2015 20:45:47,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,Na,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:46:26,1642765752,5/24/2015 20:45:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ADJUVANT INTERFERON ALFA 2A treatment in STAGE II CUTANEOUS MELANOMA,N/A,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 20:53:28,1642768459,5/24/2015 20:52:41,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],treatment primary,I didn´t select none.,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372798,5/24/2015 21:02:17,1642771629,5/24/2015 21:01:49,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treatment,n/a,100,42,-1,126,69,TWrex-cause,800844-FS1,"Pehamberger H, Soyer HP, Steiner A et al. ADJUVANT INTERFERON ALFA 2A treatment in resected primary STAGE II CUTANEOUS MELANOMA",STAGE II CUTANEOUS MELANOMA,ADJUVANT INTERFERON ALFA 2A
725372799,5/24/2015 19:56:32,1642752950,5/24/2015 19:55:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reduced recurrences,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 19:58:24,1642753452,5/24/2015 19:57:41,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",An of with a of,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:22:00,1642759534,5/24/2015 20:21:05,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",An of with a of,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:39:48,1642764004,5/24/2015 20:39:09,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],analysis,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:44:24,1642765167,5/24/2015 20:43:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],reduced,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:45:07,1642765377,5/24/2015 20:43:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:48:37,1642766474,5/24/2015 20:48:05,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analysis,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:51:47,1642767800,5/24/2015 20:50:48,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",An analysis of five trials with a total of 799 patients showed that begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:55:13,1642769169,5/24/2015 20:54:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ACYCLOVIR reduced cesarean deliveries for GENITAL HERPES,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 20:59:24,1642770575,5/24/2015 20:58:51,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[PREVENTS],[PREVENTS],reduced recurrences,I didn´t select none.,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 21:07:53,1642773655,5/24/2015 21:06:56,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[PREVENTS],[PREVENTS],reduced recurrences,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 21:25:04,1642778765,5/24/2015 21:24:52,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],showed,n/a,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 21:33:51,1642781783,5/24/2015 21:32:58,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],reduced,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 21:33:57,1642781810,5/24/2015 21:33:18,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],reduced recurrences,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372799,5/24/2015 21:41:24,1642784003,5/24/2015 21:39:56,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PREVENTS],[PREVENTS],reduced,N/A,190,70,-1,203,79,TWrex-cause,800603-FS1,• An analysis of five trials with a total of 799 patients showed that ACYCLOVIR begun at 36 weeks' gestation reduced both HSV recurrences at the time of delivery and cesarean deliveries for GENITAL HERPES ( 29.,GENITAL HERPES,ACYCLOVIR
725372800,5/24/2015 18:58:57,1642722860,5/24/2015 18:58:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],clinical trials in patients with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:03:23,1642724993,5/24/2015 19:02:44,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:03:30,1642725022,5/24/2015 19:02:45,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],in patients with ACQUIRED,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:04:41,1642725670,5/24/2015 19:03:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],trials ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),na,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:05:02,1642725831,5/24/2015 19:04:44,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:05:21,1642726043,5/24/2015 19:05:04,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],AIDS clinical trials groups: ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:05:55,1642726257,5/24/2015 19:05:26,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:05:59,1642726310,5/24/2015 19:04:42,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],in patients with,n/a,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:10:53,1642728495,5/24/2015 19:10:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],in patients with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:12:19,1642729119,5/24/2015 19:11:57,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],and,n/a,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:15:26,1642730365,5/24/2015 19:15:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],in patients with,n/a,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:18:47,1642733225,5/24/2015 19:17:49,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],in patients with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:24:46,1642740335,5/24/2015 19:23:50,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",clinical trials in patients with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:27:01,1642741418,5/24/2015 19:26:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],clinical trials,n/a,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372800,5/24/2015 19:27:03,1642741442,5/24/2015 19:26:40,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,141,87,-1,154,97,TWrex-cause,800967-FS1,"AIDS clinical trials groups: phase I/II study of combination 2′,3′ dideoxycytidine and ZIDOVUDINE in patients with ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS) and advanced AIDS related complex.",ACQUIRED IMMUNODEFFICIENCY SYNDROME (AIDS),ZIDOVUDINE
725372801,5/24/2015 20:50:46,1642767351,5/24/2015 20:50:23,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],Caused,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 21:07:03,1642773410,5/24/2015 21:06:16,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS Caused by LEISHMANIA PARASITES,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 21:08:07,1642773737,5/24/2015 21:07:54,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[CAUSES],[CAUSES],Caused by,I didn´t select none.,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 21:40:09,1642783529,5/24/2015 21:39:40,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 21:44:20,1642784764,5/24/2015 21:43:56,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 21:58:55,1642789141,5/24/2015 21:56:13,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:03:36,1642790581,5/24/2015 22:03:11,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[CAUSES],[CAUSES],Caused,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:05:06,1642790912,5/24/2015 22:04:51,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:17:05,1642795530,5/24/2015 22:16:33,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[CAUSES],[CAUSES],Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:27:29,1642799658,5/24/2015 22:26:54,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[CAUSES],[CAUSES],Caused by,Says the insect causes the disease,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:36:04,1642802296,5/24/2015 22:35:38,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],Caused by,n/a,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 22:48:04,1642806018,5/24/2015 22:47:48,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS Caused by LEISHMANIA PARASITES,n/a,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 23:02:45,1642809866,5/24/2015 23:01:34,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",Caused by,N/A,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 23:16:27,1642813521,5/24/2015 23:14:38,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[CAUSES],[CAUSES],Caused,i chose something,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372801,5/24/2015 23:17:02,1642813650,5/24/2015 23:16:44,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],Caused,Na,161,230,1,217,250,TWrex-cause,810929-FS1,"Commonly presents with abdominal pain, weight loss, hematochezia, or melena  Colonoscopy with tissue biopsy is necessary to differentiate colorectal cancer from CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS  Caused by LEISHMANIA PARASITES transmitted by sand fly bites.",CHRONIC INTESTINAL SCHISTOSOMIASIS VISCERAL LEISHMANIASIS,LEISHMANIA PARASITES
725372802,5/24/2015 21:44:32,1642784818,5/24/2015 21:44:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],are prominent features of,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 22:10:01,1642792685,5/24/2015 22:09:40,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],begin early in life,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 22:18:08,1642796170,5/24/2015 22:17:47,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SYMPTOM],[SYMPTOM],prominent features,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 22:26:07,1642799215,5/24/2015 22:25:08,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",prominent features of,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 22:39:45,1642803472,5/24/2015 22:38:39,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],prominent features of,Says they are features of,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 22:51:46,1642807011,5/24/2015 22:51:31,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],VOCAL AND MOTOR TICS are prominent features of TOURETTE SYNDROME,n/a,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:21:21,1642814841,5/24/2015 23:20:37,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],features,Na,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:21:32,1642814874,5/24/2015 23:21:15,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[SYMPTOM],[SYMPTOM],prominent features of,i chose something,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:25:06,1642815855,5/24/2015 23:22:52,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[PART_OF],[PART_OF],are prominent features of,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:32:37,1642817540,5/24/2015 23:32:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],features of,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:35:12,1642818296,5/24/2015 23:34:23,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[SYMPTOM],[SYMPTOM],are prominent features,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:35:19,1642818313,5/24/2015 23:34:30,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [MANIFESTATION] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",begin early and are prominent features,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:35:44,1642818416,5/24/2015 23:34:51,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",prominent features of,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:53:11,1642823013,5/24/2015 23:51:59,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM] [IS_A] [PART_OF],"[SYMPTOM]
[IS_A]
[PART_OF]",VOCAL AND MOTOR TICS are prominent of TOURETTE SYNDROME,N/A,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372802,5/24/2015 23:57:59,1642824618,5/24/2015 23:57:22,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",VOCAL AND MOTOR TICS are prominent features of TOURETTE SYNDROME,n/a,0,94,1,19,111,TWrex-cause,814691-FS1,VOCAL AND MOTOR TICS that begin early in life and then wax and wane are prominent features of TOURETTE SYNDROME (TS.,VOCAL AND MOTOR TICS,TOURETTE SYNDROME
725372803,5/24/2015 19:02:07,1642724300,5/24/2015 19:01:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],reduced symptoms,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:06:44,1642726624,5/24/2015 19:06:36,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[TREATS],[TREATS],reduced symptoms of,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:08:14,1642727296,5/24/2015 19:08:05,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:09:50,1642727979,5/24/2015 19:09:27,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],LACTULOSE reduced symptoms HEPATIC ENCEPHALOPATHY,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:10:03,1642728073,5/24/2015 19:09:16,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [PART_OF] [IS_A] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",symptoms of an with a,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:12:13,1642729060,5/24/2015 19:11:57,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],reduced symptoms of,n/a,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:13:15,1642729448,5/24/2015 19:11:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY,na,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:14:18,1642729882,5/24/2015 19:13:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],symptoms of,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:14:41,1642730046,5/24/2015 19:14:25,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],reduced symptoms of HEPATIC,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:17:45,1642732040,5/24/2015 19:17:15,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:18:22,1642732711,5/24/2015 19:18:01,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],reduced symptoms,n/a,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:23:41,1642739678,5/24/2015 19:23:13,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],symptoms of,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:28:43,1642742318,5/24/2015 19:28:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],reduced symptoms,n/a,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:29:22,1642742653,5/24/2015 19:28:57,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM] [PART_OF] [ASSOCIATED_WITH] [IS_A],"[SYMPTOM]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of with a,N/A,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372803,5/24/2015 19:29:27,1642742711,5/24/2015 19:28:45,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],reduced symptoms,N/a,30,0,-1,51,9,TWrex-cause,804252-FS1,LACTULOSE reduced symptoms of HEPATIC ENCEPHALOPATHY in an RCT (tvml 110tvml ) Labetalol  Noncardioselective b blocker with a 1 blocking properties.,HEPATIC ENCEPHALOPATHY,LACTULOSE
725372804,5/24/2015 20:50:21,1642767225,5/24/2015 20:50:01,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treated,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 20:57:51,1642770020,5/24/2015 20:57:11,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"pretreatment before percutaneous coronary intervention reduced cardiovascular death,",n/a,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 21:06:16,1642773152,5/24/2015 21:05:33,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced MYOCARDIAL INFARCTION,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 21:07:50,1642773618,5/24/2015 21:07:10,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],pretreatment before,I didn´t select none.,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 21:39:38,1642783368,5/24/2015 21:39:02,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],pretreatment before,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 21:43:55,1642784614,5/24/2015 21:43:02,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],recurrent,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 21:56:12,1642788419,5/24/2015 21:53:15,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],reduced,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:03:09,1642790444,5/24/2015 22:02:25,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[TREATS],[TREATS],treated,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:04:50,1642790876,5/24/2015 22:04:36,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],pretreatment before,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:16:28,1642795215,5/24/2015 22:16:01,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],treated with,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:26:53,1642799410,5/24/2015 22:25:41,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[PREVENTS],[PREVENTS],reduced,Says this reduced how many times this happened,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:35:24,1642802130,5/24/2015 22:34:56,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treated with,n/a,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 22:47:46,1642805950,5/24/2015 22:47:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CLOPIDOGREL pretreatment before intervention reduced recurrent MYOCARDIAL INFARCTION,n/a,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 23:01:33,1642809558,5/24/2015 22:59:49,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[TREATS],[TREATS],reduced,N/A,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372804,5/24/2015 23:16:43,1642813574,5/24/2015 23:16:19,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treated,Na,187,80,-1,207,91,TWrex-cause,800294-FS1,"In patients with ST elevation myocardial infarction treated with fibrinolytics, CLOPIDOGREL pretreatment before percutaneous coronary intervention reduced cardiovascular death, recurrent MYOCARDIAL INFARCTION and stroke.",MYOCARDIAL INFARCTION,CLOPIDOGREL
725372805,5/24/2015 19:08:46,1642727545,5/24/2015 19:08:22,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],represent the initial stages,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:16:22,1642730843,5/24/2015 19:16:04,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[SYMPTOM],[SYMPTOM],ACUTE DIARRHEA may represent CHRONIC DIARRHEA,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:20:49,1642735972,5/24/2015 19:20:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],may represent the initial stages of,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:20:54,1642736088,5/24/2015 19:20:29,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:24:03,1642739895,5/24/2015 19:23:35,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]",stages,n/a,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:24:09,1642739985,5/24/2015 19:23:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],ACUTE DIARRHEA may represent CHRONIC DIARRHEA,na,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:24:23,1642740155,5/24/2015 19:24:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],initial stages,n/a,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:24:24,1642740162,5/24/2015 19:23:38,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],represent the initial stages of,n/a,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:27:55,1642741939,5/24/2015 19:27:10,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],may represent the initial stages of CHRONIC,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:32:13,1642744060,5/24/2015 19:31:49,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",may represent,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:32:41,1642744311,5/24/2015 19:32:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],represent initial stages,n/a,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:36:40,1642746198,5/24/2015 19:36:30,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:36:42,1642746205,5/24/2015 19:36:23,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[SYMPTOM],[SYMPTOM],ACUTE DIARRHEA represent initial stages CHRONIC DIARRHEA,NONE,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:37:18,1642746368,5/24/2015 19:36:29,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],may represent,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372805,5/24/2015 19:37:28,1642746516,5/24/2015 19:36:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ACUTE DIARRHEA,N/A,60,9,1,75,23,TWrex-cause,813242-FS1,"Finally, ACUTE DIARRHEA may represent the initial stages of CHRONIC DIARRHEA",CHRONIC DIARRHEA,ACUTE DIARRHEA
725372806,5/24/2015 19:44:38,1642749243,5/24/2015 19:44:19,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],EYE DISEASE PREDNISONE prevents worsening,NONE,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 19:45:57,1642749733,5/24/2015 19:45:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]",prevents,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 19:50:39,1642751237,5/24/2015 19:50:04,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [SYMPTOM] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",with with of symptoms,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 19:50:54,1642751299,5/24/2015 19:50:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevents worsening and alleviates symptoms,n/a,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 19:53:42,1642752015,5/24/2015 19:51:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],EYE DISEASE,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 19:53:59,1642752137,5/24/2015 19:53:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],prevents worsening,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:13:51,1642757604,5/24/2015 20:13:24,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[ASSOCIATED_WITH] [SYMPTOM] [PART_OF],"[SYMPTOM]
[ASSOCIATED_WITH]
[PART_OF]",with with of symptoms,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:31:57,1642762135,5/24/2015 20:31:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevents worsening,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:32:49,1642762309,5/24/2015 20:31:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",n/a,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:34:59,1642762842,5/24/2015 20:34:34,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",prevents,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:36:23,1642763170,5/24/2015 20:36:01,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.,n/a,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:38:03,1642763587,5/24/2015 20:37:46,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],PREDNISONE prevents worsening,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:43:00,1642764803,5/24/2015 20:42:41,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevents,n/a,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:44:39,1642765274,5/24/2015 20:44:00,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],EYE DISEASE PREDNISONE prevents worsening,N/A,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372806,5/24/2015 20:45:23,1642765453,5/24/2015 20:45:04,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PREVENTS],[PREVENTS],prevents,Na,47,91,-1,57,101,TWrex-cause,804893-FS1,"However, in patients with clinically important EYE DISEASE especially those with diplopia, PREDNISONE prevents worsening in one fourth of patients and alleviates symptoms in most.",EYE DISEASE,PREDNISONE
725372807,5/24/2015 19:58:06,1642753393,5/24/2015 19:57:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:02:22,1642754488,5/24/2015 20:01:04,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",treatment of caused by or,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:47:35,1642766111,5/24/2015 20:47:22,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:47:44,1642766195,5/24/2015 20:47:23,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:49:51,1642766919,5/24/2015 20:48:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Clostridium Infections Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by Clostridium perfringens or other CLOSTRIDIUM,n/a,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:50:05,1642767120,5/24/2015 20:49:51,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 20:53:59,1642768760,5/24/2015 20:53:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",120 Clostridium Infections Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by Clostridium perfringens or other CLOSTRIDIUM,n/a,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:00:08,1642770830,5/24/2015 20:59:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by CLOSTRIDIUM,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:01:10,1642771240,5/24/2015 21:00:56,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[CAUSES],[CAUSES],caused by,I didn´t select none.,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:35:40,1642782258,5/24/2015 21:35:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:37:18,1642782717,5/24/2015 21:36:32,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:47:12,1642785544,5/24/2015 21:46:49,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],treatment of,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:52:18,1642787223,5/24/2015 21:52:07,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 21:57:53,1642788888,5/24/2015 21:57:27,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[CAUSES],[CAUSES],caused,n,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372807,5/24/2015 22:01:49,1642790065,5/24/2015 21:59:06,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[CAUSES],[CAUSES],caused by,N/A,74,159,1,111,170,TWrex-cause,810254-FS1,120  Clostridium Infections  Alternative to penicillin G for treatment of CLOSTRIDIAL MYONECROSIS (GAS GANGRENE) caused by  Clostridium perfringens  or other  CLOSTRIDIUM,CLOSTRIDIAL MYONECROSIS (GAS GANGRENE),CLOSTRIDIUM
725372808,5/24/2015 18:55:59,1642721441,5/24/2015 18:55:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 18:56:27,1642721691,5/24/2015 18:56:06,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],"caused by bacteria, with ENTEROTOXIGENIC",N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 18:58:19,1642722662,5/24/2015 18:57:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TRAVELER'S DIARRHEA caused by ENTEROTOXIGENIC ESCHERICHIA COLI,na,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 18:59:10,1642722976,5/24/2015 18:58:24,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",of of caused by with,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:00:15,1642723477,5/24/2015 18:59:21,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:02:59,1642724777,5/24/2015 19:02:44,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[CAUSES],[CAUSES],cause.,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:03:03,1642724818,5/24/2015 19:02:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[CAUSES],[CAUSES],TRAVELER'S DIARRHEA caused by ENTEROTOXIGENIC ESCHERICHIA COLI,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:03:14,1642724875,5/24/2015 19:02:54,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[CAUSES],[CAUSES],TRAVELER'S DIARRHEA caused by ENTEROTOXIGENIC ESCHERICHIA COLI,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:07:12,1642726844,5/24/2015 19:06:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],are caused by,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:10:27,1642728280,5/24/2015 19:10:08,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]","caused bacteria,",n/a,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:11:58,1642728933,5/24/2015 19:11:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],cause.,n/a,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:14:54,1642730133,5/24/2015 19:14:39,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],caused by,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:17:55,1642732251,5/24/2015 19:16:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:24:23,1642740156,5/24/2015 19:22:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372808,5/24/2015 19:24:47,1642740336,5/24/2015 19:24:15,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",of of caused by with cause.,N/A,21,70,1,39,103,TWrex-cause,810012-FS1,"Over 75% of cases of TRAVELER'S DIARRHEA are caused by bacteria, with ENTEROTOXIGENIC  ESCHERICHIA COLI  being the most frequent cause.",TRAVELER'S DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI
725372809,5/24/2015 19:02:56,1642724734,5/24/2015 19:02:36,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],was significantly superior to,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:10:55,1642728514,5/24/2015 19:10:18,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[OTHER],[OTHER],SKELETAL COCCIDIOIDOMYCOSIS was superior to FLUCONAZOLE,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:11:22,1642728658,5/24/2015 19:10:46,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",with of of,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:14:07,1642729854,5/24/2015 19:12:48,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for to after 1 year of therapy.,n/a,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:14:35,1642729980,5/24/2015 19:14:06,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],SKELETAL COCCIDIOIDOMYCOSIS itraconazole was superior to FLUCONAZOLE,na,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:15:03,1642730231,5/24/2015 19:14:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",was significantly superior to,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:16:50,1642731138,5/24/2015 19:15:35,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],itraconazole was significantly superior to FLUCONAZOLE,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:18:24,1642732760,5/24/2015 19:18:01,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],FLUCONAZOLE,n/a,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:19:19,1642733765,5/24/2015 19:18:40,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy.,n/a,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:25:11,1642740490,5/24/2015 19:24:41,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],therapy.,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:29:20,1642742645,5/24/2015 19:29:04,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],response rates,n/a,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:30:20,1642743158,5/24/2015 19:29:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of of,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:30:40,1642743321,5/24/2015 19:30:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],COCCIDIOIDOMYCOSIS,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:30:58,1642743506,5/24/2015 19:30:15,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],was superior therapy.,N/A,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372809,5/24/2015 19:31:16,1642743609,5/24/2015 19:30:32,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],SKELETAL COCCIDIOIDOMYCOSIS significantly superior to FLUCONAZOLE response,NONE,18,89,-1,44,100,TWrex-cause,804655-FS1,"49   However, for SKELETAL COCCIDIOIDOMYCOSIS itraconazole was significantly superior to FLUCONAZOLE with response rates of 70% versus 30% after 1 year of therapy.",SKELETAL COCCIDIOIDOMYCOSIS,FLUCONAZOLE
725372810,5/24/2015 19:45:15,1642749482,5/24/2015 19:44:39,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ENDOMETRIOMAS require surgical excision if they cause PAIN,NONE,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 19:46:31,1642749918,5/24/2015 19:45:59,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],cause,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 19:51:20,1642751388,5/24/2015 19:50:42,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",OF cause or,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 19:51:23,1642751394,5/24/2015 19:50:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",they cause,n/a,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 19:54:21,1642752214,5/24/2015 19:53:44,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ENDOMETRIOMAS,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 19:55:51,1642752763,5/24/2015 19:53:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:14:20,1642757759,5/24/2015 20:13:56,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",OF cause or,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:33:10,1642762435,5/24/2015 20:31:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],cause,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:33:42,1642762563,5/24/2015 20:32:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [CAUSES],"[CAUSES]
[LOCATION]",SURGICAL EXCISION OF OVARIAN MASSES Ovarian Endometriosis Cysts (Endometriomas) ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,n/a,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:35:28,1642762899,5/24/2015 20:35:00,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],cause,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:36:44,1642763257,5/24/2015 20:36:24,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,n/a,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:38:42,1642763744,5/24/2015 20:38:04,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[CAUSES],[CAUSES],if they cause,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:43:18,1642764850,5/24/2015 20:43:01,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:45:27,1642765468,5/24/2015 20:44:40,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],ENDOMETRIOMAS cause PAIN,N/A,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372810,5/24/2015 20:45:46,1642765568,5/24/2015 20:45:24,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],excision,Na,136,82,1,139,95,TWrex-cause,813004-FS1,SURGICAL EXCISION OF OVARIAN MASSES  Ovarian Endometriosis Cysts (Endometriomas)  ENDOMETRIOMAS require surgical excision if they cause PAIN or become enlarged.,PAIN,ENDOMETRIOMAS
725372811,5/24/2015 19:41:49,1642748228,5/24/2015 19:41:12,false,neodev,1,31743852,GBR,G5,Faversham,85.210.123.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ACQUIRED RESPIRATORY VIRAL INFECTIONS such PARAINFLUENZA VIRUS influenza viruses,",NONE,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:43:09,1642748698,5/24/2015 19:42:37,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",have been associated with,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:45:26,1642749565,5/24/2015 19:45:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],RESPIRATORY VIRAL INFECTIONS,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:45:54,1642749731,5/24/2015 19:45:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have been associated with,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:46:34,1642749964,5/24/2015 19:45:54,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",other with,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:47:08,1642750058,5/24/2015 19:46:32,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],such as,n/a,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 19:47:50,1642750378,5/24/2015 19:46:32,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other community associated with,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:10:58,1642756826,5/24/2015 20:10:17,false,neodev,1,31329809,USA,OH,Columbus,64.79.65.23,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",other with,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:21:50,1642759473,5/24/2015 20:21:23,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"such as respiratory syncytial virus (RSV),",no  comment,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:23:59,1642760030,5/24/2015 20:23:27,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,-,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:27:23,1642760784,5/24/2015 20:26:07,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",n/a,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:27:27,1642760804,5/24/2015 20:26:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INFECTIONS such as,N/A,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:28:22,1642761144,5/24/2015 20:28:04,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:28:53,1642761343,5/24/2015 20:28:44,false,neodev,1,31789301,USA,"","",178.62.105.32,[NONE],[NONE],no,no,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372811,5/24/2015 20:32:54,1642762336,5/24/2015 20:31:30,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]","The relationship between CMV infection and BOS has been inconsistent; ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus been associated with late developing BOS.",n/a,86,167,1,122,186,TWrex-cause,810377-FS1,"The relationship between CMV infection and BOS has been inconsistent; other community ACQUIRED RESPIRATORY VIRAL INFECTIONS such as respiratory syncytial virus (RSV), PARAINFLUENZA VIRUS influenza viruses, and metapneumovirus have been associated with late developing BOS.",ACQUIRED RESPIRATORY VIRAL INFECTIONS,PARAINFLUENZA VIRUS
725372812,5/24/2015 19:04:59,1642725782,5/24/2015 19:04:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],for induction of remission,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:13:22,1642729470,5/24/2015 19:12:49,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],TRANSDERMAL NICOTINE for ULCERATIVE COLITIS,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:16:02,1642730655,5/24/2015 19:15:03,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of of of of a,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:17:50,1642732166,5/24/2015 19:17:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for induction,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:19:25,1642733938,5/24/2015 19:17:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for induction of remission in,n/a,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:20:02,1642734795,5/24/2015 19:18:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS,na,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:20:17,1642735180,5/24/2015 19:19:50,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],induction remission,n/a,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:21:07,1642736430,5/24/2015 19:20:43,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],induction of remission,n/a,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:24:06,1642739968,5/24/2015 19:21:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],induction of remission in ULCERATIVE,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:28:28,1642742209,5/24/2015 19:27:57,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],for induction of remission,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:30:50,1642743411,5/24/2015 19:30:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],induction remission,n/a,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:33:12,1642744560,5/24/2015 19:32:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ulcerative colitis,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:33:28,1642744775,5/24/2015 19:32:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],induction of remission in,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:33:38,1642744837,5/24/2015 19:32:40,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],for induction of remission,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372812,5/24/2015 19:34:14,1642745086,5/24/2015 19:32:09,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of of of of,N/A,302,251,-1,319,271,TWrex-cause,804658-FS1,for induction of remission in ulcerative colitis (Cochrane Review)  Probiotics for induction of remission in ulcerative colitis (Cochrane Review)  Azathioprine and 6 mercaptopurine for maintenance of remission in ulcerative colitis (Cochrane Review)  TRANSDERMAL NICOTINE for induction of remission in ULCERATIVE COLITIS (Cochrane Review)  Colorectal Disease  Laparoscopic surgery for ulcerative colitis   a meta analysis.,ULCERATIVE COLITIS,TRANSDERMAL NICOTINE
725372813,5/24/2015 19:06:26,1642726509,5/24/2015 19:06:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:14:40,1642730044,5/24/2015 19:14:25,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],MAGNESIUM SULFATE THERAPY in TOXEMIA,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:18:08,1642732445,5/24/2015 19:17:32,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of by of,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:19:04,1642733578,5/24/2015 19:18:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],THERAPY in,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:21:41,1642737190,5/24/2015 19:20:39,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Potentiation of in,n/a,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:21:48,1642737404,5/24/2015 19:21:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],Potentiation of MAGNESIUM SULFATE THERAPY in TOXEMIA,na,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:22:00,1642737721,5/24/2015 19:21:46,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:23:16,1642739234,5/24/2015 19:22:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],muscle relaxants,n/a,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:25:35,1642740685,5/24/2015 19:25:03,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],THERAPY in TOXEMIA,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:30:03,1642742996,5/24/2015 19:29:32,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],Potentiation of,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:31:35,1642743749,5/24/2015 19:31:20,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],muscle relaxants,n/a,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:35:05,1642745447,5/24/2015 19:34:48,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",of by of,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:35:16,1642745535,5/24/2015 19:34:37,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],TOXEMIA,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:35:22,1642745603,5/24/2015 19:34:51,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[MANIFESTATION],[MANIFESTATION],relaxants MAGNESIUM SULFATE THERAPY TOXEMIA of pregnancy.,NONE,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372813,5/24/2015 19:35:36,1642745692,5/24/2015 19:34:52,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],THERAPY of,N/A,65,36,-1,71,61,TWrex-cause,800336-FS1,Potentiation of muscle relaxants by MAGNESIUM SULFATE THERAPY in TOXEMIA of pregnancy.,TOXEMIA,MAGNESIUM SULFATE THERAPY
725372814,5/24/2015 19:05:25,1642726086,5/24/2015 19:05:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],that occurs in,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:13:59,1642729732,5/24/2015 19:13:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[CAUSES],[CAUSES],VARICELLA after exposure to VZV,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:16:40,1642731029,5/24/2015 19:16:06,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",an with,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:18:37,1642733048,5/24/2015 19:17:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],exposure to,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:20:16,1642735143,5/24/2015 19:19:30,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],occurs after exposure to,n/a,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:20:33,1642735509,5/24/2015 19:20:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],VARICELLA occurs after exposure to VZV,na,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:21:17,1642736637,5/24/2015 19:20:19,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],exposure,n/a,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:22:04,1642737844,5/24/2015 19:21:08,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],occurs after exposure,n/a,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:25:02,1642740445,5/24/2015 19:24:07,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],occurs after exposure to VZV,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:28:51,1642742365,5/24/2015 19:28:30,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],after exposure to,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:31:06,1642743525,5/24/2015 19:30:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],occurs after exposure,n/a,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:33:54,1642744928,5/24/2015 19:33:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],VARICELLA,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:34:04,1642745018,5/24/2015 19:32:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],occurs in,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:34:18,1642745102,5/24/2015 19:33:40,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PART_OF],[PART_OF],exposure to,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372814,5/24/2015 19:34:27,1642745181,5/24/2015 19:33:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",occurs in an immunized person after exposure to,N/A,15,78,-1,23,81,TWrex-cause,803170-FS1,'Breakthrough' VARICELLA that occurs in an immunized person after exposure to VZV is almost always mild with low grade fever and few cutaneous lesions,VARICELLA,VZV
725372815,5/24/2015 18:58:28,1642722692,5/24/2015 18:57:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],especially,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:02:40,1642724606,5/24/2015 19:02:01,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:02:44,1642724627,5/24/2015 19:02:13,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[IS_A],[IS_A],especially ABDOMINAL,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:02:59,1642724780,5/24/2015 19:02:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],OBESITY especially ABDOMINAL OBESITY;,na,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:04:40,1642725668,5/24/2015 19:04:15,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[IS_A],[IS_A],especially,n/a,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:04:43,1642725677,5/24/2015 19:04:05,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[IS_A],[IS_A],especially,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:05:03,1642725850,5/24/2015 19:04:51,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],OBESITY especially ABDOMINAL OBESITY;,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:05:25,1642726082,5/24/2015 19:05:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[IS_A],[IS_A],OBESITY especially ABDOMINAL OBESITY;,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:10:27,1642728286,5/24/2015 19:10:04,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],especially,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:11:55,1642728928,5/24/2015 19:11:40,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],especially,n/a,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:15:02,1642730227,5/24/2015 19:14:07,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],especially,n/a,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:17:48,1642732123,5/24/2015 19:17:27,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],especially,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:23:44,1642739710,5/24/2015 19:22:56,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],especially,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:26:47,1642741256,5/24/2015 19:26:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],especially,n/a,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372815,5/24/2015 19:26:55,1642741332,5/24/2015 19:26:31,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],ABDOMINAL OBESITY;,N/A,229,248,1,235,265,TWrex-cause,814182-FS1,"C]  Specific recommendation: • Consider preventive measures, such as weight loss, diet, and exercise, in patients at risk of developing NAFLD, particularly those with the metabolic syndrome (diabetes or impaired fasting glucose; OBESITY especially ABDOMINAL OBESITY; dyslipidemia; and hypertension.",OBESITY,ABDOMINAL OBESITY
725372816,5/24/2015 19:46:31,1642749917,5/24/2015 19:45:58,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],"TEGASEROD treatment, outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",NONE,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 19:52:37,1642751620,5/24/2015 19:52:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],controlled trials,n/a,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 19:53:40,1642752003,5/24/2015 19:52:51,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[OTHER]",or with or other with,N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:17:02,1642758447,5/24/2015 20:16:22,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]","or with treatment, or with",N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:36:18,1642763134,5/24/2015 20:34:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],"compared no treatment,",N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:36:41,1642763250,5/24/2015 20:36:20,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],"treatment,",N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:37:48,1642763502,5/24/2015 20:36:30,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]","Study selection and assessment: Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",n/a,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:40:02,1642764110,5/24/2015 20:39:33,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],controlled trials,N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:44:53,1642765336,5/24/2015 20:44:17,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Study,n/a,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:47:08,1642765940,5/24/2015 20:46:44,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PART_OF],[PART_OF],relevant,Na,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:47:18,1642766015,5/24/2015 20:46:49,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Study selection and assessment: Randomized controlled trials (RCTs) or quasirandomized controlled trials published,n/a,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:48:20,1642766411,5/24/2015 20:47:22,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],TEGASEROD relevant outcomes in patients with OBJECTIVELY DOCUMENTED IBS,N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 20:54:49,1642769017,5/24/2015 20:53:58,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],"treatment,",I didn´t select none.,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 21:03:20,1642771984,5/24/2015 21:02:49,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],"treatment, intervention,",n/a,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372816,5/24/2015 21:17:54,1642776631,5/24/2015 21:17:06,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],"compared with placebo,",N/A,268,146,-1,293,155,TWrex-cause,800581-FS1,"Study selection and assessment:  Randomized controlled trials (RCTs) or quasirandomized controlled trials published in any language that compared TEGASEROD with placebo, no treatment, or any other intervention, and reported relevant outcomes in patients (≥ 12 y) with OBJECTIVELY DOCUMENTED IBS",OBJECTIVELY DOCUMENTED IBS,TEGASEROD
725372817,5/24/2015 21:11:00,1642774523,5/24/2015 21:10:25,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[SYMPTOM],[SYMPTOM],with recurrent,I didn´t select none.,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 21:42:19,1642784287,5/24/2015 21:41:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],with recurrent,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 21:51:51,1642787004,5/24/2015 21:50:58,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],with recurrent,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:08:02,1642791887,5/24/2015 22:07:39,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],congenital bullous disease,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:14:54,1642794521,5/24/2015 22:14:23,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SYMPTOM],[SYMPTOM],with recurrent,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:21:29,1642797848,5/24/2015 22:20:40,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SYMPTOM],[SYMPTOM],is a congenital bullous disease,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:30:23,1642800545,5/24/2015 22:29:51,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[SYMPTOM],[SYMPTOM],with recurrent,Says this happens during the disease,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:37:48,1642802845,5/24/2015 22:37:34,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],with recurrent,n/a,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 22:49:38,1642806468,5/24/2015 22:49:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a disease with recurrent BLISTERING,n/a,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:08:08,1642811522,5/24/2015 23:07:14,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SIDE_EFFECT] [ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",with recurrent,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:18:34,1642814010,5/24/2015 23:18:07,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],"recurrent scarring,",Na,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:19:11,1642814203,5/24/2015 23:18:44,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[SYMPTOM],[SYMPTOM],disease with recurrent,i chose something,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:25:15,1642815890,5/24/2015 23:22:33,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SYMPTOM],[SYMPTOM],RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is congenital bullous disease with recurrent BLISTERING,n/a,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:25:30,1642815966,5/24/2015 23:25:11,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],with recurrent,n/a,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372817,5/24/2015 23:26:36,1642816187,5/24/2015 23:25:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],with recurrent,N/A,117,27,1,126,69,TWrex-cause,814860-FS1,"33  Epidermolysis Bullosa  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA is a congenital bullous disease with recurrent BLISTERING and scarring, particularly on the hands and feet [ see 2:IX Vesiculobullous Diseases.",BLISTERING,RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
725372818,5/24/2015 19:07:25,1642726936,5/24/2015 19:07:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:15:31,1642730406,5/24/2015 19:15:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[SYMPTOM],[SYMPTOM],"CLL symptoms, PROGRESSIVE LYMPHADENOPATHY",N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:19:49,1642734541,5/24/2015 19:19:02,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]","symptoms, an",N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:20:13,1642735120,5/24/2015 19:19:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],patients with Richter's transformation,N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:23:17,1642739262,5/24/2015 19:22:47,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],extra nodal,n/a,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:23:22,1642739380,5/24/2015 19:22:42,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],have sudden onset of,n/a,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:23:27,1642739470,5/24/2015 19:22:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"have PROGRESSIVE LYMPHADENOPATHY increased LDH,",na,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:23:51,1642739750,5/24/2015 19:23:36,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],"symptoms,",n/a,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:26:53,1642741339,5/24/2015 19:25:57,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],"have sudden onset of B symptoms, PROGRESSIVE",N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:31:25,1642743668,5/24/2015 19:30:25,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],have sudden onset,N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:32:12,1642744053,5/24/2015 19:31:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],have sudden onset,n/a,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:36:02,1642745882,5/24/2015 19:35:24,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[CAUSES],[CAUSES],"CLL patients Richter's transformation sudden symptoms, PROGRESSIVE LYMPHADENOPATHY",NONE,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:36:01,1642745884,5/24/2015 19:35:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]","with of symptoms, an and/or",N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:36:10,1642745970,5/24/2015 19:35:38,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],"have symptoms,",N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372818,5/24/2015 19:36:26,1642746067,5/24/2015 19:36:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PROGRESSIVE LYMPHADENOPATHY,N/A,107,0,1,133,4,TWrex-cause,813930-FS1,"CLL patients with Richter's transformation (approximately 10%) have sudden onset of B symptoms, PROGRESSIVE LYMPHADENOPATHY extra nodal involvement, an M spike, increased LDH, and/or hypercalcemia.",PROGRESSIVE LYMPHADENOPATHY,CLL
725372819,5/24/2015 19:04:11,1642725447,5/24/2015 19:03:51,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:12:21,1642729132,5/24/2015 19:11:53,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Keywords: HYPERTENSION LOSARTAN ACP,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:14:20,1642729893,5/24/2015 19:13:16,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],onset,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:16:54,1642731191,5/24/2015 19:16:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",reduced,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:17:16,1642731519,5/24/2015 19:15:52,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"from the text, I would guess they are just a list of keywords meaningless to me at this point",104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:17:29,1642731773,5/24/2015 19:16:51,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Keywords: HYPERTENSION LOSARTAN,na,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:19:31,1642734079,5/24/2015 19:19:16,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Atenolol,n/a,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:20:25,1642735346,5/24/2015 19:20:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],reduced,n/a,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:21:33,1642736962,5/24/2015 19:19:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],Losartan reduced strokes more than,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:27:26,1642741610,5/24/2015 19:26:31,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[PREVENTS],[PREVENTS],reduced,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:30:09,1642743027,5/24/2015 19:29:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],reduced strokes,n/a,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:31:39,1642743789,5/24/2015 19:31:13,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],and,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:32:09,1642744042,5/24/2015 19:31:39,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],reduced,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:32:47,1642744355,5/24/2015 19:31:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],strokes,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372819,5/24/2015 19:32:58,1642744431,5/24/2015 19:31:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],reduced strokes and new onset,N/A,104,126,-1,115,134,TWrex-cause,803339-FS1,Losartan reduced strokes and new onset diabetes more than atenolol in essential hypertension  Keywords: HYPERTENSION Atenolol LOSARTAN  ACP Journal Club.,HYPERTENSION,LOSARTAN
725372820,5/24/2015 19:02:34,1642724579,5/24/2015 19:02:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],consists mainly of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:10:17,1642728179,5/24/2015 19:09:51,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[SYMPTOM],[SYMPTOM],TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists of HYPOPARATHYROIDISM,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:10:41,1642728415,5/24/2015 19:10:07,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",a of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:12:46,1642729298,5/24/2015 19:12:15,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],consists mainly of,n/a,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:14:04,1642729826,5/24/2015 19:13:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists of HYPOPARATHYROIDISM,na,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:14:39,1642730040,5/24/2015 19:14:19,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],consists mainly of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:15:35,1642730428,5/24/2015 19:14:42,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],"consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM",N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:18:00,1642732325,5/24/2015 19:17:46,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"adrenal insufficiency,",n/a,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:18:38,1642733077,5/24/2015 19:18:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],consists,n/a,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:24:39,1642740296,5/24/2015 19:23:43,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",consists mainly of,N/AN/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:29:04,1642742498,5/24/2015 19:28:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],consists mainly of,n/a,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:29:47,1642742884,5/24/2015 19:29:26,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",a of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:30:13,1642743077,5/24/2015 19:29:29,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],consists,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:30:36,1642743301,5/24/2015 19:29:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PART_OF],[PART_OF],consists mainly of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372820,5/24/2015 19:30:42,1642743334,5/24/2015 19:29:37,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]",consists mainly of,N/A,85,2,1,102,42,TWrex-cause,814748-FS1,"a TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME consists mainly of adrenal insufficiency, HYPOPARATHYROIDISM and mucocutaneous candidiasis.",HYPOPARATHYROIDISM,TYPE I AUTOIMMUNE POLYGLANDULAR SYNDROME
725372821,5/24/2015 19:04:35,1642725637,5/24/2015 19:04:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:12:47,1642729301,5/24/2015 19:12:22,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[CAUSES],[CAUSES],BACTERIA cause SEPTIC ARTHRITIS,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:14:59,1642730197,5/24/2015 19:14:24,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],of of,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:17:27,1642731736,5/24/2015 19:16:55,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],most frequent cause of,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:17:50,1642732160,5/24/2015 19:17:16,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],most frequent cause of,n/a,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:18:06,1642732421,5/24/2015 19:17:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],BACTERIA the most frequent cause of SEPTIC ARTHRITIS,na,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:19:49,1642734544,5/24/2015 19:19:33,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",frequent cause,n/a,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:20:41,1642735702,5/24/2015 19:20:26,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],cause,n/a,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:21:54,1642737549,5/24/2015 19:21:34,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],the most frequent cause of SEPTIC,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:27:56,1642741946,5/24/2015 19:27:28,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],most frequent cause of,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:30:29,1642743242,5/24/2015 19:30:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],in addition to cause,n/a,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:32:05,1642744021,5/24/2015 19:31:43,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of of of,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:32:39,1642744321,5/24/2015 19:32:11,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],cause of,N/a,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:34:50,1642745374,5/24/2015 19:31:52,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[SYMPTOM],[SYMPTOM],BACTERIA in ARTHRITIS,None,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372821,5/24/2015 19:35:09,1642745473,5/24/2015 19:34:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause of,N/A,118,67,1,133,75,TWrex-cause,811119-FS1,BC]  Specific recommendation: • Know the local sensitivity data of BACTERIA in addition to the most frequent cause of SEPTIC ARTHRITIS in your local community to aid the selection of antimicrobial agents before culture and sensitivity results.,SEPTIC ARTHRITIS,BACTERIA
725372822,5/24/2015 20:48:30,1642766436,5/24/2015 20:48:09,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],present,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 20:51:35,1642767712,5/24/2015 20:51:01,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as well as,n/a,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 20:55:43,1642769398,5/24/2015 20:55:08,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Mumps other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION,n/a,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:02:38,1642771724,5/24/2015 21:02:01,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[CAUSES],[CAUSES],may occur,I didn´t select none.,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:03:14,1642771955,5/24/2015 21:02:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[OTHER],[OTHER],PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION,The relation is when these infections present themselves.,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:37:34,1642782805,5/24/2015 21:36:27,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as well as,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:39:43,1642783397,5/24/2015 21:38:59,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as well as,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:50:43,1642786552,5/24/2015 21:49:13,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],as well as,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 21:59:52,1642789505,5/24/2015 21:59:24,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:03:05,1642790438,5/24/2015 22:02:41,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[MANIFESTATION],[MANIFESTATION],"present in the winter,",N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:13:32,1642793878,5/24/2015 22:12:27,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[MANIFESTATION],[MANIFESTATION],most often present,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:23:37,1642798564,5/24/2015 22:22:52,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as well as,Indislcates they are similar,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:33:58,1642801545,5/24/2015 22:33:36,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PART_OF],[PART_OF],as well as,n/a,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:40:57,1642803933,5/24/2015 22:39:55,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[ASSOCIATED_WITH],[ASSOCIATED_WITH],as well as,N/A,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372822,5/24/2015 22:46:27,1642805508,5/24/2015 22:46:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION,n/a,20,16,1,44,46,TWrex-cause,810309-FS1,"Mumps and other PARAINFLUENZA VIRUS INFECTIONS as well as INFLUENZA VIRUS INFECTION most often present in the winter, although they may occur at any time of year.",INFLUENZA VIRUS INFECTION,PARAINFLUENZA VIRUS INFECTIONS
725372823,5/24/2015 18:56:20,1642721627,5/24/2015 18:56:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],manifests,N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 18:58:05,1642722530,5/24/2015 18:56:28,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],"spinal muscular atrophy, symptoms TYPE III",N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 18:59:01,1642722908,5/24/2015 18:58:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE),na,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:00:01,1642723382,5/24/2015 18:59:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",symptoms is a,N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:02:22,1642724484,5/24/2015 19:00:17,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[NONE],[NONE],n/a,"it is written in brakets behind assuming it is also named as ... but I can not select a word, the brakes themself mean => also known as",105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:03:21,1642724973,5/24/2015 19:03:04,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:03:21,1642724979,5/24/2015 19:03:00,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",manifests,N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:03:42,1642725139,5/24/2015 19:03:15,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[IS_A],[IS_A],TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:07:56,1642727152,5/24/2015 19:07:13,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:10:44,1642728431,5/24/2015 19:10:28,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],usually manifests,n/a,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:12:30,1642729166,5/24/2015 19:11:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,is the same,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:15:35,1642730438,5/24/2015 19:14:56,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:19:16,1642733753,5/24/2015 19:17:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],(WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:25:19,1642740527,5/24/2015 19:24:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM] [PART_OF] [IS_A],"[SYMPTOM]
[IS_A]
[PART_OF]",symptoms of is is,N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372823,5/24/2015 19:25:46,1642740802,5/24/2015 19:24:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],type II TYPE III (WOHLFART KUGELBERG WELANDER DISEASE),N/A,105,139,1,136,174,TWrex-cause,814190-FS1,"In  type II (intermediate) spinal muscular atrophy,  symptoms usually manifest between age 3 and 15 mo;  TYPE III SPINAL MUSCULAR ATROPHY (WOHLFART KUGELBERG WELANDER DISEASE)  usually manifests between age 15 mo and 19 yr. Findings are similar to those of type I, but progression is slower and life expectancy is longer; some patients have a normal life span.",TYPE III SPINAL MUSCULAR ATROPHY,WOHLFART KUGELBERG WELANDER DISEASE
725372824,5/24/2015 19:34:25,1642745154,5/24/2015 19:34:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],25% reduction,n/a,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:40:04,1642747570,5/24/2015 19:39:30,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],trial ARB LOSARTAN HYPERTENSION 25% reduction relative risk,NONE,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:41:24,1642748059,5/24/2015 19:40:48,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],comparing with,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:41:30,1642748101,5/24/2015 19:41:03,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTENSION,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:43:07,1642748691,5/24/2015 19:42:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],trial in patients with,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:43:13,1642748712,5/24/2015 19:42:01,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],in patients with,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:43:51,1642748998,5/24/2015 19:43:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a with with a of a with,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 19:45:40,1642749673,5/24/2015 19:44:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",In a trial there was a reduction in the risk of a stroke,n/a,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:08:44,1642756167,5/24/2015 20:08:13,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a with with a of a with,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:19:32,1642758980,5/24/2015 20:18:36,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in patients with,no comment,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:22:30,1642759687,5/24/2015 20:21:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]","In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",n/a,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:22:36,1642759746,5/24/2015 20:22:20,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],trial,-,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:24:54,1642760232,5/24/2015 20:23:55,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],25% reduction in risk,N/A,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:27:22,1642760774,5/24/2015 20:26:59,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],reduction,n/a,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372824,5/24/2015 20:28:02,1642760990,5/24/2015 20:27:51,false,neodev,1.0,31789301,USA,"","",178.62.105.32,[NONE],[NONE],no,no,86,56,-1,97,68,TWrex-cause,804792-FS1,"In a trial comparing the beta blocker atenolol with the ARB LOSARTAN in patients with HYPERTENSION and left ventricular hypertrophy, there was a 25% reduction in the relative risk of a first stroke with the ARB.",HYPERTENSION,ARB LOSARTAN
725372825,5/24/2015 21:09:49,1642774262,5/24/2015 21:09:19,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[IS_A],[IS_A],also called,I didn´t select none.,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 21:41:36,1642784081,5/24/2015 21:41:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],also called,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 21:46:18,1642785203,5/24/2015 21:45:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],also called,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:04:57,1642790877,5/24/2015 22:04:13,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[IS_A],[IS_A],also called,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:07:14,1642791644,5/24/2015 22:06:20,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[LOCATION],[LOCATION],disease of the nipples,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:14:02,1642794089,5/24/2015 22:13:36,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[OTHER],[OTHER],also called,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:20:00,1642797162,5/24/2015 22:19:04,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SYMPTOM],[SYMPTOM],should not be confused with,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:29:23,1642800295,5/24/2015 22:28:51,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also called,Says this is another name for it,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:36:56,1642802538,5/24/2015 22:36:33,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[OTHER],[OTHER],also called,n/a,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 22:48:59,1642806279,5/24/2015 22:48:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",METABOLIC BONE DISEASE also called PAGET'S DISEASE,n/a,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 23:06:16,1642810954,5/24/2015 23:05:49,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[IS_A],[IS_A],also called,N/A,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 23:17:44,1642813884,5/24/2015 23:17:19,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[MANIFESTATION],[MANIFESTATION],also called,Na,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 23:17:57,1642813927,5/24/2015 23:17:36,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",called,i chose something,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 23:18:33,1642814015,5/24/2015 23:18:03,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A],[IS_A],the METABOLIC BONE DISEASE also called PAGET'S DISEASE,n/a,63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372825,5/24/2015 23:25:41,1642815986,5/24/2015 23:23:46,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],also called,"same name for different diseases, potentially unrelated",63,98,-1,84,113,TWrex-cause,802098-FS1,Paget's disease of the nipples should not be confused with the METABOLIC BONE DISEASE also called PAGET'S DISEASE,METABOLIC BONE DISEASE,PAGET'S DISEASE
725372826,5/24/2015 21:44:08,1642784705,5/24/2015 21:43:51,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],is a common sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 21:55:46,1642788273,5/24/2015 21:54:53,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],sign,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:09:39,1642792571,5/24/2015 22:09:27,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],common sign,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:17:45,1642795946,5/24/2015 22:17:26,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SYMPTOM],[SYMPTOM],common sign,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:25:01,1642798947,5/24/2015 22:24:33,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[SYMPTOM],[SYMPTOM],is a common sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:38:38,1642803067,5/24/2015 22:37:50,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],a common sign of,Says it indicates the disease,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:39:59,1642803579,5/24/2015 22:39:50,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],common sign of,n/a,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 22:51:30,1642806939,5/24/2015 22:51:06,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],IRON DEFICIENCY is a common sign of CELIAC DISEASE,n/a,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:20:36,1642814607,5/24/2015 23:20:20,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],sign,Na,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:21:14,1642814815,5/24/2015 23:20:44,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[SYMPTOM],[SYMPTOM],common sign of,i chose something,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:22:50,1642815315,5/24/2015 23:20:50,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SYMPTOM] [MANIFESTATION] [SIDE_EFFECT] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]
[PART_OF]",is a common sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:30:18,1642817059,5/24/2015 23:29:53,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SYMPTOM],[SYMPTOM],IRON DEFICIENCY is common sign of CELIAC DISEASE,n/a,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:32:12,1642817436,5/24/2015 23:30:42,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:34:22,1642818008,5/24/2015 23:33:16,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is a common sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372826,5/24/2015 23:34:37,1642818080,5/24/2015 23:33:57,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",is a common sign of,N/A,2,38,1,16,52,TWrex-cause,814232-FS1,• IRON DEFICIENCY is a common sign of CELIAC DISEASE and is often seen in newly diagnosed patients.,IRON DEFICIENCY,CELIAC DISEASE
725372827,5/24/2015 19:48:00,1642750418,5/24/2015 19:47:39,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[CAUSES],[CAUSES],VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE,NONE,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 19:53:41,1642752004,5/24/2015 19:53:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],Mortality following SUPPRESSION by,n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 19:55:28,1642752612,5/24/2015 19:54:52,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:18:34,1642758815,5/24/2015 20:18:09,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by of,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:37:53,1642763528,5/24/2015 20:37:21,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],by,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:40:20,1642764174,5/24/2015 20:39:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:40:23,1642764179,5/24/2015 20:38:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],SUPPRESSION by,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:45:55,1642765615,5/24/2015 20:45:25,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],following,n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:48:46,1642766529,5/24/2015 20:48:24,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the original design concept of the Cardiac Arrhythmia Suppression Trial,n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:51:26,1642767622,5/24/2015 20:49:55,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 20:56:45,1642769657,5/24/2015 20:56:06,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],by,I didn´t select none.,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 21:04:35,1642772473,5/24/2015 21:04:00,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],by,n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 21:21:14,1642777664,5/24/2015 21:19:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],SUPPRESSION,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 21:24:06,1642778480,5/24/2015 21:23:51,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],Arrhythmia,n/a,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372827,5/24/2015 21:31:12,1642780613,5/24/2015 21:29:41,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],by,N/A,20,58,-1,53,67,TWrex-cause,804674-FS1,"Mortality following VENTRICULAR ARRHYTHMIA SUPPRESSION by ENCAINIDE flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST.",VENTRICULAR ARRHYTHMIA SUPPRESSION,ENCAINIDE
725372828,5/24/2015 19:42:49,1642748531,5/24/2015 19:41:50,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[OTHER],[OTHER],MAGNESIUM SULPHATE placebo for PRE ECLAMPSIA,NONE,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 19:43:41,1642748858,5/24/2015 19:43:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],comparing with,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 19:47:13,1642750117,5/24/2015 19:46:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",a with,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 19:47:14,1642750120,5/24/2015 19:45:27,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PRE ECLAMPSIA,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 19:48:55,1642750729,5/24/2015 19:47:51,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],comparing with placebo for,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 19:49:03,1642750763,5/24/2015 19:47:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],trial for,n/a,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:11:30,1642756950,5/24/2015 20:11:02,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",a with,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:22:09,1642759590,5/24/2015 20:21:51,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],with placebo for,n/a,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:24:34,1642760172,5/24/2015 20:24:05,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],trial,-,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:28:13,1642761064,5/24/2015 20:27:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,n/a,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:28:16,1642761077,5/24/2015 20:27:28,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],trial comparing with,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:29:28,1642761536,5/24/2015 20:28:24,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CONTRAINDICATES],[CONTRAINDICATES],comparing,n/a,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:32:53,1642762339,5/24/2015 20:32:07,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],randomised trial placebo,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:33:13,1642762437,5/24/2015 20:32:55,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,n/a,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372828,5/24/2015 20:36:35,1642763223,5/24/2015 20:36:13,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],for,N/A,95,59,-1,107,77,TWrex-cause,804675-FS1,2007 03 11  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
725372829,5/24/2015 19:43:15,1642748739,5/24/2015 19:42:51,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],CEFOTETAN treatment serious INTRA ABDOMINAL SEPSIS:,NONE,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 19:44:03,1642749040,5/24/2015 19:43:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 19:47:51,1642750381,5/24/2015 19:47:16,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [IS_A],"[TREATS]
[IS_A]",treatment of a,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 19:49:06,1642750771,5/24/2015 19:47:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CEFOTETAN,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 19:49:29,1642750857,5/24/2015 19:49:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 19:50:02,1642751012,5/24/2015 19:48:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:12:06,1642757133,5/24/2015 20:11:34,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of a,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:22:32,1642759719,5/24/2015 20:22:11,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the treatment of serious,n/a,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:24:52,1642760223,5/24/2015 20:24:41,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:28:31,1642761215,5/24/2015 20:28:17,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:29:04,1642761454,5/24/2015 20:28:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,n/a,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:33:08,1642762434,5/24/2015 20:32:55,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:34:06,1642762668,5/24/2015 20:33:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",CEFOTETAN the treatment serious INTRA ABDOMINAL SEPSIS: controlled clinical trial.,n/a,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:36:52,1642763282,5/24/2015 20:36:35,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],in the treatment of,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372829,5/24/2015 20:42:49,1642764767,5/24/2015 20:42:12,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS:,N/A,38,0,-1,59,9,TWrex-cause,800991-FS1,CEFOTETAN in the treatment of serious INTRA ABDOMINAL SEPSIS: a controlled clinical trial.,INTRA ABDOMINAL SEPSIS,CEFOTETAN
725372830,5/24/2015 19:33:51,1642744911,5/24/2015 19:33:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed incidentally,n/a,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:38:34,1642747033,5/24/2015 19:38:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[IS_A]",Symptoms is is or of,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:39:07,1642747179,5/24/2015 19:38:28,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CLL diagnosed evaluation of ASYMPTOMATIC LYMPHADENOPATHY,NONE,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:40:02,1642747566,5/24/2015 19:39:20,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],is diagnosed,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:40:19,1642747662,5/24/2015 19:39:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CLL,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:40:55,1642747867,5/24/2015 19:39:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or through evaluation of,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:41:35,1642748140,5/24/2015 19:40:37,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],through evaluation of,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:42:40,1642748496,5/24/2015 19:41:57,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[PART_OF]",Symptoms is or of,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:44:22,1642749167,5/24/2015 19:43:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is often diagnosed incidentally,n/a,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 19:45:36,1642749625,5/24/2015 19:45:25,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",CLL LYMPHADENOPATHY,drugs,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 20:07:51,1642755909,5/24/2015 20:07:09,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[SYMPTOM] [IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[IS_A]
[PART_OF]",Symptoms is is tests or of,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 20:18:10,1642758689,5/24/2015 20:17:35,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[TREATS],[TREATS],is often diagnosed incidentally during routine blood tests or through evaluation of,no comment,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 20:19:36,1642758990,5/24/2015 20:18:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",Symptoms and Signs Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,n/a,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 20:21:52,1642759472,5/24/2015 20:21:39,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,-,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372830,5/24/2015 20:22:28,1642759665,5/24/2015 20:21:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed through evaluation,N/A,136,48,1,163,51,TWrex-cause,813148-FS1,Symptoms and Signs  Onset is usually insidious; CLL is often diagnosed incidentally during routine blood tests or through evaluation of ASYMPTOMATIC LYMPHADENOPATHY,ASYMPTOMATIC LYMPHADENOPATHY,CLL
725372831,5/24/2015 19:01:43,1642724122,5/24/2015 19:01:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:06:34,1642726537,5/24/2015 19:06:23,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",associated with,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:08:04,1642727216,5/24/2015 19:07:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN associated with POSTHERPETIC NEURALGIA:,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:09:12,1642727762,5/24/2015 19:08:33,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of of with a,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:09:25,1642727835,5/24/2015 19:08:52,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN associated with POSTHERPETIC NEURALGIA:,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:11:40,1642728785,5/24/2015 19:11:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN associated with POSTHERPETIC NEURALGIA:,na,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:11:56,1642728929,5/24/2015 19:11:33,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:13:41,1642729549,5/24/2015 19:13:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:14:23,1642729898,5/24/2015 19:14:06,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with POSTHERPETIC,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:17:14,1642731494,5/24/2015 19:16:56,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:17:59,1642732316,5/24/2015 19:17:42,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:23:11,1642739148,5/24/2015 19:22:40,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:28:31,1642742223,5/24/2015 19:28:18,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],associated with,n/a,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:28:51,1642742367,5/24/2015 19:28:31,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of of with,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372831,5/24/2015 19:30:11,1642743062,5/24/2015 19:28:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],NEUROPATHIC PAIN,N/A,55,123,1,70,145,TWrex-cause,813425-FS1,Cost effectiveness of pregabalin for the management of NEUROPATHIC PAIN associated with diabetic peripheral neuropathy and POSTHERPETIC NEURALGIA: a Canadian perspective.,NEUROPATHIC PAIN,POSTHERPETIC NEURALGIA
725372832,5/24/2015 19:05:15,1642725988,5/24/2015 19:05:01,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],THERAPY for NEUROCYSTICERCOSIS:,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:05:55,1642726279,5/24/2015 19:05:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY for,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:14:23,1642729906,5/24/2015 19:14:03,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS:,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:17:28,1642731772,5/24/2015 19:16:48,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]",a of treatment.,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:18:50,1642733295,5/24/2015 19:18:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],THERAPY for,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:20:38,1642735620,5/24/2015 19:20:17,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],THERAPY for,n/a,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:21:06,1642736399,5/24/2015 19:20:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS:,na,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:21:45,1642737318,5/24/2015 19:21:18,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",for,n/a,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:22:47,1642738685,5/24/2015 19:22:12,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],THERAPY,n/a,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:29:31,1642742749,5/24/2015 19:28:52,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],THERAPY for,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:31:19,1642743639,5/24/2015 19:31:07,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment.,n/a,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:34:36,1642745242,5/24/2015 19:33:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],NEUROCYSTICERCOSIS:,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:34:45,1642745319,5/24/2015 19:34:18,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS],"[TREATS]
[IS_A]",a of treatment.,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:34:50,1642745371,5/24/2015 19:34:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],THERAPY for,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372832,5/24/2015 19:35:08,1642745463,5/24/2015 19:34:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for treatment.,N/A,24,0,-1,41,19,TWrex-cause,803503-FS1,ALBENDAZOLE THERAPY for NEUROCYSTICERCOSIS: a prospective double blind trial comparing 7 versus 14 days of treatment.,NEUROCYSTICERCOSIS,ALBENDAZOLE THERAPY
725372833,5/24/2015 18:59:46,1642723266,5/24/2015 18:59:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:04:45,1642725688,5/24/2015 19:04:07,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",is an of by,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:05:00,1642725796,5/24/2015 19:04:33,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],(ABPA) is an IGE,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:05:32,1642726155,5/24/2015 19:05:22,false,bitcoinget,1.0,21614812,USA,NJ,Burlington,50.153.125.0,[IS_A],[IS_A],is an,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:06:23,1642726485,5/24/2015 19:06:00,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[IS_A],[IS_A],ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS is an IGE MEDIATED HYPERSENSITIVITY REACTION,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:07:07,1642726821,5/24/2015 19:06:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION,na,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:07:08,1642726834,5/24/2015 19:06:28,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[MANIFESTATION],[MANIFESTATION],ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS is an IGE MEDIATED HYPERSENSITIVITY REACTION,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:08:25,1642727387,5/24/2015 19:07:13,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],is an REACTION to,n/a,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:11:45,1642728876,5/24/2015 19:11:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[IS_A],[IS_A],is an,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:13:00,1642729385,5/24/2015 19:12:37,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is an,n/a,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:16:46,1642731066,5/24/2015 19:16:04,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],is an,n/a,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:20:05,1642734834,5/24/2015 19:19:39,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],is an,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:26:17,1642740990,5/24/2015 19:25:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],is an,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:27:28,1642741620,5/24/2015 19:27:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",is an of by,N/A,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372833,5/24/2015 19:27:29,1642741643,5/24/2015 19:27:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is an,n/a,0,94,1,38,132,TWrex-cause,811127-FS1,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS  ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) is an IGE MEDIATED HYPERSENSITIVITY REACTION to colonization of the airways by  Aspergillus  species.,ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS,IGE MEDIATED HYPERSENSITIVITY REACTION
725372834,5/24/2015 19:34:57,1642745411,5/24/2015 19:34:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:40:52,1642747861,5/24/2015 19:40:23,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],INTRAVENOUS UNFRACTIONATED HEPARIN initial treatment of PULMONARY EMBOLISM,NONE,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:42:08,1642748349,5/24/2015 19:41:47,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:43:58,1642749012,5/24/2015 19:43:36,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HEPARIN,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:44:17,1642749136,5/24/2015 19:43:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:45:14,1642749471,5/24/2015 19:44:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [TREATS] [PART_OF],"[TREATS]
[IS_A]
[PART_OF]","A, treatment of",N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:45:26,1642749576,5/24/2015 19:44:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 19:46:16,1642749836,5/24/2015 19:45:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:09:35,1642756392,5/24/2015 20:09:16,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:21:03,1642759324,5/24/2015 20:20:25,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the initial treatment of,no comment,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:23:06,1642759857,5/24/2015 20:22:52,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:25:02,1642760260,5/24/2015 20:24:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM,n/a,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:26:06,1642760406,5/24/2015 20:25:33,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:27:49,1642760934,5/24/2015 20:27:35,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372834,5/24/2015 20:28:27,1642761174,5/24/2015 20:28:15,false,neodev,1.0,31789301,USA,"","",178.62.105.32,[NONE],[NONE],no,no,173,110,-1,190,144,TWrex-cause,800998-FS1,"2]  Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus INTRAVENOUS UNFRACTIONATED HEPARIN in the initial treatment of PULMONARY EMBOLISM",PULMONARY EMBOLISM,INTRAVENOUS UNFRACTIONATED HEPARIN
725372835,5/24/2015 19:54:00,1642752148,5/24/2015 19:53:42,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],approved for the treatment of,n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 19:56:10,1642752831,5/24/2015 19:55:31,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by treatment of,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:19:18,1642758955,5/24/2015 20:18:38,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",by treatment of,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:38:20,1642763663,5/24/2015 20:37:54,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],approved FDA treatment,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:41:02,1642764361,5/24/2015 20:40:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:41:19,1642764410,5/24/2015 20:40:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Agents Approved for Short Term Use Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY",n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:46:28,1642765761,5/24/2015 20:45:56,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:49:22,1642766786,5/24/2015 20:48:47,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Agents Approved for Short Term Use Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE approved by the FDA for short term treatment of OBESITY",n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:52:08,1642767954,5/24/2015 20:51:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PHENTERMINE treatment of OBESITY,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 20:57:05,1642769742,5/24/2015 20:56:47,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],approved by,I didn´t select none.,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 21:05:30,1642772760,5/24/2015 21:04:36,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],short term treatment,n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 21:24:25,1642778558,5/24/2015 21:24:08,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[PREVENTS],[PREVENTS],"Benzphetamine,",n/a,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 21:30:53,1642780504,5/24/2015 21:30:00,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment of,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 21:32:18,1642781150,5/24/2015 21:31:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for the short term treatment of,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372835,5/24/2015 21:33:08,1642781516,5/24/2015 21:30:21,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],treatment of,N/A,166,98,-1,172,109,TWrex-cause,800759-FS1,"Agents Approved for Short Term Use  Benzphetamine, phendimetrazine, diethylpropion, mazindol, and PHENTERMINE are approved by the FDA for the short term treatment of OBESITY (weeks.",OBESITY,PHENTERMINE
725372836,5/24/2015 19:08:19,1642727321,5/24/2015 19:07:28,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:16:03,1642730668,5/24/2015 19:15:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.149.130,[TREATS],[TREATS],treatment with PROPRANOLOL,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:20:24,1642735327,5/24/2015 19:19:53,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:20:29,1642735425,5/24/2015 19:20:15,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:23:34,1642739590,5/24/2015 19:23:18,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:23:37,1642739618,5/24/2015 19:23:24,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment with,n/a,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:23:51,1642739749,5/24/2015 19:23:30,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ESSENTIAL TREMOR: treatment with PROPRANOLOL,na,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:24:02,1642739879,5/24/2015 19:23:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:27:09,1642741491,5/24/2015 19:26:55,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:31:48,1642743855,5/24/2015 19:31:27,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],treatment with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:32:25,1642744141,5/24/2015 19:32:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:36:22,1642746058,5/24/2015 19:36:02,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],ESSENTIAL TREMOR: treatment with PROPRANOLOL,NONE,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:36:28,1642746111,5/24/2015 19:36:04,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:36:29,1642746114,5/24/2015 19:36:12,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment with,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372836,5/24/2015 19:37:32,1642746626,5/24/2015 19:36:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,0,33,-1,15,44,TWrex-cause,800913-FS1,ESSENTIAL TREMOR: treatment with PROPRANOLOL,ESSENTIAL TREMOR,PROPRANOLOL
725372837,5/24/2015 22:12:45,1642793571,5/24/2015 22:11:57,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[SYMPTOM],[SYMPTOM],neuromuscular poisoning,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 22:28:41,1642800059,5/24/2015 22:28:11,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[CAUSES],[CAUSES],is neuromuscular poisoning,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 22:53:17,1642807404,5/24/2015 22:53:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BOTULISM is poisoning from CLOSTRIDIUM BOTULINUM TOXIN,n/a,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:15:36,1642813319,5/24/2015 23:15:12,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[CAUSES],[CAUSES],poisoning from,Says it causes,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:23:14,1642815412,5/24/2015 23:23:05,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[CAUSES],[CAUSES],neuromuscular poisoning,i chose something,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:23:34,1642815484,5/24/2015 23:23:11,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],neuromuscular poisoning,Na,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:36:10,1642818500,5/24/2015 23:35:07,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:41:38,1642820161,5/24/2015 23:40:18,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",is neuromuscular poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:49:36,1642821925,5/24/2015 23:48:44,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[IS_A] [MANIFESTATION],"[MANIFESTATION]
[IS_A]",is neuromuscular poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:50:23,1642822100,5/24/2015 23:49:33,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",is neuromuscular poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/24/2015 23:50:49,1642822181,5/24/2015 23:49:34,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",is neuromuscular poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/25/2015 00:00:00,1642825117,5/24/2015 23:59:33,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[CAUSES],[CAUSES],BOTULISM is neuromuscular poisoning from CLOSTRIDIUM BOTULINUM TOXIN,n/a,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/25/2015 00:01:50,1642825708,5/25/2015 00:00:52,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],BOTULISM is neuromuscular poisoning from CLOSTRIDIUM BOTULINUM TOXIN,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/25/2015 00:25:59,1642833629,5/25/2015 00:25:26,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SYMPTOM],[SYMPTOM],poisoning from,N/A,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372837,5/25/2015 00:34:55,1642836229,5/25/2015 00:33:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],poisoning,none,0,52,1,7,80,TWrex-cause,810958-FS1,BOTULISM  BOTULISM is neuromuscular poisoning from  CLOSTRIDIUM BOTULINUM  TOXIN,BOTULISM,CLOSTRIDIUM BOTULINUM  TOXIN
725372838,5/24/2015 21:08:25,1642773807,5/24/2015 21:07:58,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],GABAPENTIN for ACUTE AND CHRONIC PAIN,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 21:09:18,1642774111,5/24/2015 21:08:42,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],for,I didn´t select none.,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 21:41:09,1642783868,5/24/2015 21:40:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 21:45:24,1642785036,5/24/2015 21:44:43,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:01:53,1642790086,5/24/2015 22:00:24,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:04:11,1642790667,5/24/2015 22:03:58,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[TREATS],[TREATS],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:06:11,1642791167,5/24/2015 22:05:21,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:18:59,1642796638,5/24/2015 22:18:05,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],for ACUTE AND CHRONIC PAIN,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:28:51,1642800132,5/24/2015 22:28:04,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],for,"Says it's ""for""",15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:36:32,1642802446,5/24/2015 22:36:21,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],for,n/a,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 22:48:31,1642806151,5/24/2015 22:48:21,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],GABAPENTIN for ACUTE AND CHRONIC PAIN,n/a,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 23:05:48,1642810822,5/24/2015 23:04:07,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[OTHER],[OTHER],for,N/A,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 23:17:18,1642813741,5/24/2015 23:17:02,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],for,Na,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 23:17:35,1642813815,5/24/2015 23:17:07,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[TREATS],[TREATS],for,i chose something,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372838,5/24/2015 23:18:02,1642813969,5/24/2015 23:17:45,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],GABAPENTIN for ACUTE AND CHRONIC PAIN,n/a,15,0,-1,36,10,TWrex-cause,804161-FS1,GABAPENTIN for ACUTE AND CHRONIC PAIN,ACUTE AND CHRONIC PAIN,GABAPENTIN
725372839,5/24/2015 22:23:02,1642798353,5/24/2015 22:22:51,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],treatment usually,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 22:30:52,1642800715,5/24/2015 22:30:27,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[TREATS],[TREATS],treatment may be,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 22:55:03,1642807875,5/24/2015 22:54:24,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],One treatment usually is successful; PEDICULICIDE after 7 10 days if LICE are detected,n/a,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:24:42,1642815699,5/24/2015 23:24:08,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],initial treatment),Says it's and alternative treatment,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:25:31,1642815963,5/24/2015 23:24:51,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,Na,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:39:00,1642819349,5/24/2015 23:38:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment may,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:49:14,1642821855,5/24/2015 23:48:53,false,prodege,1.0,6309240,USA,CA,San Diego,66.27.81.67,[OTHER],[OTHER],treatment) alternative,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:55:54,1642823949,5/24/2015 23:54:31,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[OTHER],[OTHER],or an alternative,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:55:54,1642823958,5/24/2015 23:54:11,false,elite,1.0,31722487,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",One after initial treatment,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/24/2015 23:57:36,1642824507,5/24/2015 23:56:06,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [MANIFESTATION],"[TREATS]
[MANIFESTATION]",treatment or live after 7 10 days,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/25/2015 00:05:34,1642826894,5/25/2015 00:04:19,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],treatment or live lice are observed or alternative PEDICULICIDE after 10 days if LICE are detected,n/a,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/25/2015 00:06:48,1642827340,5/25/2015 00:05:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],is treatment PEDICULICIDE if LICE are detected,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/25/2015 00:35:31,1642836486,5/25/2015 00:34:55,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],alternative,none,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/25/2015 00:39:14,1642837595,5/25/2015 00:38:41,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",alternative after 7 10 days if LICE or nits are detected,n/a,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372839,5/25/2015 01:05:29,1642845069,5/25/2015 01:04:54,false,gptking,1.0,31799065,USA,IL,Marion,50.45.40.174,[TREATS],[TREATS],PEDICULICIDE LICE,N/A,283,251,-1,286,263,TWrex-cause,805130-FS1,"1 ,   89  One treatment usually is successful;  1 ,   65   treatment may be repeated with 1% permethrin cream (especially if hair is shampooed 7 days after initial treatment or live lice are observed ≥7 days after initial treatment) or an alternative PEDICULICIDE after 7 10 days if LICE or nits are detected at the hair skin junction.",LICE,PEDICULICIDE
725372840,5/24/2015 19:54:47,1642752377,5/24/2015 19:54:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],often produces side effects of,n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 19:57:05,1642753145,5/24/2015 19:56:13,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[IS_A]
[PART_OF]",side effects of of,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:20:36,1642759270,5/24/2015 20:19:37,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [PART_OF] [SIDE_EFFECT],"[SIDE_EFFECT]
[IS_A]
[PART_OF]",is side effects of of,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:38:45,1642763769,5/24/2015 20:38:21,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SIDE_EFFECT],[SIDE_EFFECT],side effects,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:42:19,1642764654,5/24/2015 20:41:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SIDE_EFFECT],[SIDE_EFFECT],produces side effects,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:42:20,1642764660,5/24/2015 20:41:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:47:17,1642765998,5/24/2015 20:46:28,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SIDE_EFFECT],[SIDE_EFFECT],side effects,n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:50:14,1642767156,5/24/2015 20:49:23,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SIDE_EFFECT],[SIDE_EFFECT],"OXYBUTYNIN short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:52:58,1642768248,5/24/2015 20:52:10,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SIDE_EFFECT],[SIDE_EFFECT],OXYBUTYNIN produces side effects GLAUCOMA,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 20:57:44,1642769954,5/24/2015 20:57:07,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[SIDE_EFFECT],[SIDE_EFFECT],side effects of,I didn´t select none.,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 21:06:15,1642773139,5/24/2015 21:05:34,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SIDE_EFFECT],[SIDE_EFFECT],side effects,n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 21:24:37,1642778606,5/24/2015 21:24:26,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],often,n/a,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 21:31:55,1642780956,5/24/2015 21:30:55,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],exacerbation of,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 21:32:51,1642781353,5/24/2015 21:32:19,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SIDE_EFFECT],[SIDE_EFFECT],often produces significant anticholinergic side effects of,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372840,5/24/2015 21:34:36,1642782014,5/24/2015 21:33:09,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[CAUSES],[CAUSES],exacerbation of,N/A,135,0,1,142,10,TWrex-cause,811093-FS1,"OXYBUTYNIN is short acting and often produces significant anticholinergic side effects of constipation, dry mouth, and exacerbation of GLAUCOMA",GLAUCOMA,OXYBUTYNIN
725372841,5/24/2015 19:33:14,1642744597,5/24/2015 19:32:59,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],reactivation results,n/a,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:37:49,1642746796,5/24/2015 19:37:28,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:37:56,1642746826,5/24/2015 19:37:23,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[CAUSES],[CAUSES],PRIMARY VZV INFECTION results HERPES ZOSTER,NONE,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:38:05,1642746885,5/24/2015 19:37:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",results in reactivation,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:38:23,1642746979,5/24/2015 19:37:33,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],(chickenpox);,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:38:37,1642747040,5/24/2015 19:37:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],results in,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:38:48,1642747110,5/24/2015 19:37:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],reactivation of infection results in,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:40:24,1642747698,5/24/2015 19:40:10,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",reactivation of infection results,n/a,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:41:13,1642747987,5/24/2015 19:40:45,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:42:53,1642748588,5/24/2015 19:42:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reactivation results in,n/a,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:45:14,1642749473,5/24/2015 19:45:01,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[CAUSES] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]",PRIMARY VZV INFECTION,Don't,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:48:52,1642750693,5/24/2015 19:47:53,false,gifthunterclub,1,31241093,GBR,C2,Brighouse,94.10.218.157,[CAUSES],[CAUSES],results in,n/a,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 19:53:19,1642751886,5/24/2015 19:50:32,false,neodev,1,31463401,USA,CA,San Jose,23.27.220.225,[CAUSES],[CAUSES],reactivation of infection results,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 20:06:16,1642755405,5/24/2015 20:05:46,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF],[PART_OF],of,N/A,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372841,5/24/2015 20:16:55,1642758425,5/24/2015 20:15:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,n/a,6,100,1,26,113,TWrex-cause,810161-FS1,49 •  PRIMARY VZV INFECTION results in varicella (chickenpox); reactivation of infection results in HERPES ZOSTER,PRIMARY VZV INFECTION,HERPES ZOSTER
725372842,5/24/2015 19:43:42,1642748850,5/24/2015 19:43:16,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],CICLOPIROX NAIL LACQUER SOLUTION 8% used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS,NONE,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 19:44:34,1642749218,5/24/2015 19:44:05,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],used to treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 19:48:34,1642750574,5/24/2015 19:47:54,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",of treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 19:49:33,1642750876,5/24/2015 19:49:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ONYCHOMYCOSIS,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 19:49:56,1642750945,5/24/2015 19:49:30,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],used to treat,n/a,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 19:51:06,1642751348,5/24/2015 19:50:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],to treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:12:33,1642757319,5/24/2015 20:12:09,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",of treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:25:07,1642760276,5/24/2015 20:24:57,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treat,-,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:29:12,1642761473,5/24/2015 20:28:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:30:01,1642761712,5/24/2015 20:29:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,n/a,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:33:25,1642762461,5/24/2015 20:33:09,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:34:56,1642762830,5/24/2015 20:34:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS,n/a,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:37:08,1642763340,5/24/2015 20:36:53,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],used to treat,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:41:19,1642764418,5/24/2015 20:41:03,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treat,n/a,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372842,5/24/2015 20:42:05,1642764552,5/24/2015 20:40:53,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CICLOPIROX NAIL LACQUER SOLUTION and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS,N/A,114,29,-1,143,61,TWrex-cause,804289-FS1,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION
725372843,5/24/2015 19:33:36,1642744823,5/24/2015 19:33:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],impending,n/a,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:38:12,1642746941,5/24/2015 19:37:53,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:38:26,1642746990,5/24/2015 19:37:57,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURES impending STATUS EPILEPTICUS,NONE,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:39:18,1642747229,5/24/2015 19:38:07,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",may be due to,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:39:28,1642747291,5/24/2015 19:38:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SEIZURES,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:39:50,1642747489,5/24/2015 19:38:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURES may be or for impending,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:40:30,1642747726,5/24/2015 19:40:25,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS],[PREVENTS],patients when SEIZURES,n/a,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:40:32,1642747746,5/24/2015 19:38:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],may be due to,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:41:52,1642748243,5/24/2015 19:41:16,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:43:55,1642749007,5/24/2015 19:42:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,various reasons for hospitalization,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 19:45:25,1642749556,5/24/2015 19:45:15,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",HOSPITALIZATION Introduction EPILEPTICUS,do,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 20:07:05,1642755682,5/24/2015 20:06:19,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],or,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 20:17:34,1642758557,5/24/2015 20:16:55,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"may be due to acute brain pathology, if consciousness does not return to normal, or for impending",no comment,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 20:18:11,1642758686,5/24/2015 20:16:56,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]","HOSPITALIZATION Introduction Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",n/a,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372843,5/24/2015 20:21:30,1642759405,5/24/2015 20:20:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],may be due to,N/A,57,164,1,64,182,TWrex-cause,814003-FS1,"HOSPITALIZATION  Introduction  Hospitalize patients when SEIZURES may be due to acute brain pathology, if consciousness does not return to normal, or for impending STATUS EPILEPTICUS",SEIZURES,STATUS EPILEPTICUS
725372844,5/24/2015 19:55:50,1642752759,5/24/2015 19:54:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS] [OTHER],"[TREATS]
[OTHER]",patients with,patient's condition,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 19:57:38,1642753318,5/24/2015 19:57:08,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,v,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:21:01,1642759312,5/24/2015 20:20:40,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:39:07,1642763832,5/24/2015 20:38:46,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],Administer,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:43:30,1642764885,5/24/2015 20:42:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,n/a,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:43:38,1642764928,5/24/2015 20:42:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PART_OF],[PART_OF],patients with,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:48:04,1642766294,5/24/2015 20:47:23,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PART_OF],[PART_OF],iron in,n/a,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:50:47,1642767365,5/24/2015 20:50:15,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,n/a,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:54:14,1642768835,5/24/2015 20:52:59,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 20:58:49,1642770309,5/24/2015 20:57:52,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],patients with,I didn´t select none.,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 21:06:53,1642773382,5/24/2015 21:06:16,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],TRANSFUSION DEPENDENT,n/a,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 21:24:50,1642778723,5/24/2015 21:24:38,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],deferoxamine,n/a,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 21:32:56,1642781388,5/24/2015 21:31:56,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],patients with,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 21:33:16,1642781588,5/24/2015 21:32:53,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],patients with,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372844,5/24/2015 21:43:05,1642784464,5/24/2015 21:42:36,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[PART_OF],[PART_OF],patients with,N/A,114,62,-1,130,99,TWrex-cause,803236-FS1,7.6 Administer deferasirox or deferoxamine to chelate iron in IRON OVERLOADED TRANSFUSION DEPENDENT patients with HEMOLYTIC ANEMIAS,HEMOLYTIC ANEMIAS,IRON OVERLOADED TRANSFUSION DEPENDENT
725372845,5/24/2015 19:56:50,1642753073,5/24/2015 19:56:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],"causes side effects, including",n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 19:59:05,1642753616,5/24/2015 19:58:28,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[CAUSES] [IS_A],"[CAUSES]
[IS_A]","causes side effects, an",N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:45:07,1642765376,5/24/2015 20:44:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]","causes side effects,",N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:46:04,1642765663,5/24/2015 20:45:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]","MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:46:09,1642765690,5/24/2015 20:45:46,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],causes,N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:48:52,1642766632,5/24/2015 20:48:37,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SIDE_EFFECT],[SIDE_EFFECT],"side effects,",n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:52:26,1642768055,5/24/2015 20:51:51,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SIDE_EFFECT] [CAUSES],"[CAUSES]
[SIDE_EFFECT]","MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness bad dreams, seizures, and PSYCHOSIS",n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:55:48,1642769424,5/24/2015 20:55:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],MEFLOQUINE causes PSYCHOSIS,N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 20:59:49,1642770714,5/24/2015 20:59:26,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[SIDE_EFFECT],[SIDE_EFFECT],"side effects,",I didn´t select none.,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:08:25,1642773809,5/24/2015 21:07:54,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SIDE_EFFECT],[SIDE_EFFECT],"causes side effects,",n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:25:25,1642778879,5/24/2015 21:25:06,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[PREVENTS],[PREVENTS],headedness,n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:34:22,1642781947,5/24/2015 21:33:59,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]","causes side effects,",N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:34:31,1642781992,5/24/2015 21:33:52,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causes,N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:42:35,1642784347,5/24/2015 21:41:25,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[SIDE_EFFECT],[SIDE_EFFECT],"causes side effects,",N/A,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372845,5/24/2015 21:51:32,1642786889,5/24/2015 21:51:21,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,157,0,1,165,10,TWrex-cause,811256-FS1,"MEFLOQUINE causes side effects, including nausea, dizziness, vertigo, light headedness (described as an inability to concentrate), bad dreams, seizures, and PSYCHOSIS",PSYCHOSIS,MEFLOQUINE
725372846,5/24/2015 21:10:19,1642774367,5/24/2015 21:09:53,false,neodev,1.0,31910622,GBR,X4,Blackwood,78.148.171.155,[TREATS],[TREATS],therapy for,I didn´t select none.,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 21:41:55,1642784129,5/24/2015 21:41:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],therapy for,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 21:50:50,1642786631,5/24/2015 21:49:50,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],therapy for,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:05:25,1642790996,5/24/2015 22:04:59,false,prodege,1.0,10959404,USA,CA,Studio City,108.217.110.104,[NONE],[NONE],none,none,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:07:38,1642791739,5/24/2015 22:07:15,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Addition of,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:14:23,1642794197,5/24/2015 22:14:03,false,bitcoinget,1.0,32114595,CAN,ON,Scarborough,70.50.111.183,[TREATS],[TREATS],fibrinolytic therapy,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:20:35,1642797470,5/24/2015 22:20:05,false,points4rewards,1.0,28703583,USA,"","",97.73.85.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Addition of,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:29:50,1642800405,5/24/2015 22:29:23,false,tremorgames,1.0,31906954,USA,NY,Middletown,74.68.51.54,[TREATS],[TREATS],therapy for,Says it's a therapy for it,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:37:33,1642802729,5/24/2015 22:36:57,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],therapy for,n/a,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 22:49:12,1642806343,5/24/2015 22:49:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ASPIRIN therapy for MYOCARDIAL INFARCTION,n/a,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 23:07:13,1642811312,5/24/2015 23:06:18,false,bitcoinget,1.0,28503763,USA,CA,San Francisco,107.217.186.64,[OTHER],[OTHER],for,N/A,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 23:18:06,1642813995,5/24/2015 23:17:45,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],therapy,Na,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 23:18:41,1642814080,5/24/2015 23:17:58,false,instagc,1.0,30721651,USA,NY,New York,69.203.110.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ASPIRIN and fibrinolytic therapy,i chose something,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 23:22:32,1642815213,5/24/2015 23:22:05,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[TREATS],[TREATS],Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION,n/a,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372846,5/24/2015 23:25:10,1642815872,5/24/2015 23:24:54,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,79,42,-1,99,49,TWrex-cause,804205-FS1,2005 03 24     Addition of clopidogrel to ASPIRIN and fibrinolytic therapy for MYOCARDIAL INFARCTION with ST segment elevation.,MYOCARDIAL INFARCTION,ASPIRIN
725372847,5/24/2015 19:44:00,1642749014,5/24/2015 19:43:44,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],GABAPENTIN effective than placebo for PAIN relief,NONE,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 19:45:03,1642749363,5/24/2015 19:44:36,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],was effective,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 19:49:31,1642750861,5/24/2015 19:48:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 19:50:21,1642751126,5/24/2015 19:50:01,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],more effective for relief,n/a,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 19:51:04,1642751337,5/24/2015 19:49:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],GABAPENTIN,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 19:52:12,1642751536,5/24/2015 19:51:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],more effective than placebo for,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:13:02,1642757425,5/24/2015 20:12:37,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[PART_OF]",effective of,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:25:32,1642760317,5/24/2015 20:25:09,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],effective,-,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:30:26,1642761834,5/24/2015 20:29:29,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],more effective,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:30:56,1642761896,5/24/2015 20:30:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life,n/a,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:33:48,1642762566,5/24/2015 20:33:26,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],placebo,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:35:35,1642762933,5/24/2015 20:34:57,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life trial.,n/a,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:37:29,1642763443,5/24/2015 20:37:10,false,clixsense,1.0,23197581,NLD,11,Den Haag,82.217.5.55,[TREATS],[TREATS],was more effective,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:42:40,1642764735,5/24/2015 20:41:35,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],effective,n/a,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372847,5/24/2015 20:43:19,1642764851,5/24/2015 20:42:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],GABAPENTIN was effective for PAIN relief,N/A,47,0,-1,50,10,TWrex-cause,804326-FS1,GABAPENTIN was more effective than placebo for PAIN relief and improvement in sleep and quality of life (1 trial.,PAIN,GABAPENTIN
725372848,5/24/2015 19:41:10,1642747980,5/24/2015 19:40:54,false,neodev,1.0,31743852,GBR,G5,Faversham,85.210.123.52,[TREATS],[TREATS],alAZTREONAM treatment of severe URINARY TRACT INFECTIONS,NONE,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:42:31,1642748465,5/24/2015 19:42:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:45:01,1642749354,5/24/2015 19:44:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:45:05,1642749399,5/24/2015 19:44:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],URINARY TRACT INFECTIONS,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:45:51,1642749715,5/24/2015 19:45:18,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",treatment of,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:46:31,1642749920,5/24/2015 19:45:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 19:46:31,1642749923,5/24/2015 19:46:18,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:10:14,1642756582,5/24/2015 20:09:39,false,neodev,1.0,31329809,USA,OH,Columbus,64.79.65.23,[IS_A] [TREATS],"[TREATS]
[IS_A]",A treatment of,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:21:22,1642759399,5/24/2015 20:21:05,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the treatment of severe,no comment,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:23:20,1642759872,5/24/2015 20:23:07,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:26:06,1642760421,5/24/2015 20:25:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [LOCATION],"[TREATS]
[LOCATION]",alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.,n/a,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:26:45,1642760574,5/24/2015 20:26:07,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:28:02,1642761013,5/24/2015 20:27:50,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:28:41,1642761303,5/24/2015 20:28:29,false,neodev,1.0,31789301,USA,"","",178.62.105.32,[NONE],[NONE],no,no,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
725372848,5/24/2015 20:31:23,1642761941,5/24/2015 20:30:50,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],treatment of severe URINARY TRACT INFECTIONS in pediatric patients.,n/a,75,38,-1,98,47,TWrex-cause,803635-FS1,"Rusconi F, Assael BM, Boccazzi A et alAZTREONAM in the treatment of severe URINARY TRACT INFECTIONS in pediatric patients.",URINARY TRACT INFECTIONS,AZTREONAM
